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Abstract 
 
Introduction: Abdominal Aortic Aneurysm (AAA) screening programmes have been carried 
out worldwide on males between the ages of 65-75 years. The results of such programmes 
show AAA screening to be beneficial and cost effective. In the Multicentre Aneurysm 
Screening Study conducted in the United Kingdom, the incidence of AAA was 4.9%. Early 
diagnoses of AAA’s have reduced AAA related deaths by 42%. 
This study investigated the incidence of AAA in Irish males between the ages of 55-75 years 
and incorporated an assessment of cardiovascular risk factors. A younger group of males 
were screened to see if there was any benefit in screening for AAA and to determine the 
incidence of cardiovascular risk factors in this younger population. 
 
Method: From April 2006 to December 2007, males ages between 55-75 years living in the 
catchment area of the hospital, were invited to participate in the screening programme. A 
ultrasound scan of their aortas was preformed and a finger prick blood test was carried out to 
assess their cardiovascular risk factor status. 
 
Results: Nine hundred and four participants were screened. Of these, 17 (1.9%) participants 
had an undiagnosed AAA, of which 4.2% were aged between 65-75years and 0.6% aged 
between 55-64 years. The incidence for hypertension, 33% had been previously diagnosed 
with hypertension, with 165 of these uncontrolled. In the participants with no history of HTN, 
31% had an elevated blood pressure reading. The study found, 26% had a previous history of 
hypercholesterolemia, with 70% of these remaining uncontrolled. Of those with no previous 
history of hypercholesterolemia, 33% had an elevated reading. The glucose results revealed 
3% of the total participants had a raised glucose level with had no previous history of DM. Of 
those who were being treated for diabetes, 49% showed poor sugar control. Only 63% (573) 
of all participants agreed to have their body mass index measured. Of these, 16% were found 
to be morbidly obese and 64% were overweight. 
 
Conclusion: The incidence of AAA in males between 65-75 years is similar to other 
worldwide studies, therefore screening would be beneficial in Ireland. However, screening 
males of 55-65 years was not proven to be beneficial. Cardiovascular risk factors, such as 
hypertension, hypercholesterolemia and diabetes are very prevalent in Ireland. In this study 
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the prevalence of cardiovascular risk factors were high. Of those who have been diagnosed 
with a cardiovascular risk factor, many remain uncontrolled despite treatment. There was also 
a larger number of the screened population undiagnosed for their risk factors. Therefore 
screening for cardiovascular risk factors is a necessity and it can easily be incorporated in to 
other screening programmes. 
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1. Introduction of abdominal aortic aneurysms (AAA) 
 
In the following thesis, I aim to show the benefit for AAA screening of Irish males. The 
results of this screening study for AAA will be analysed and compared with other 
international studies. We screened men in the 65-75 years of age group when AAA’s 
commonly occur and we also screened men aged 55-64 years to see if there was any benefit 
in screening a younger population. In addition to the AAA screening, these males were also 
screened for cardiovascular disease such as hypertension, hypercholesterolemia and diabetes 
all of which have a high incidence in present day Ireland. These figures will also be analysed 
and compared. 
And the incidence of risk factors and age of the participants will be discussed.  
 
Chapter 2 the anatomy of the aorta, its location and branches and the structure of the arterial 
wall will be discussed. 
Chapter 3 contains the literature review. The review will discuss what is an aneurysm and 
types of aneurysms that occur. The epidemiology of AAA’s and risk factors which contribute 
to AAA formation and growth will also be examined. There will be a detailed view of AAA 
screening programmes, their results and the financial burden posed by ruptured AAA’s. 
Finally there will be a review on the types of treatments available for AAA. 
Chapter 4 the methods for diagnosing AAA are reviewed and compared. As ultrasound is the 
method used for AAA screening, in this study this will be dealt with in detail. An overview of 
the physics of ultrasound will be given.  
Chapter 5 will look at the participants demographics. The result of the screening programme 
will be analysed. A comparison of the participants with AAA’s and those without AAA’s and 
their risk factors will be carried out. 
Chapter 6 is the discussion and the results obtained in this study will be looked at in detail 
and compared to findings from other studies.  
Chapter 7 is the conclusion and an overall review of the study and its results. 
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2. The Aorta: 
 
2.1 Anatomy and physiology of the Abdominal Aorta 
 
The aorta is the largest artery in the body and is the main trunk of a series of vessels, which 
convey the oxygenated blood from the heart to the tissues of the body for their nutrition. It 
commences at the upper part of the left ventricle, where it is about 3cm in diameter. It 
ascends for a short distance then arches backwards and to the left of the heart. It then 
descends within the thorax on the left of the vertebral column and inferior vena cava and 
passes into the abdominal cavity through the hiatus in the diaphragm where it becomes the 
abdominal aorta. At this point it measures approx 1.75cm in diameter. It runs longitudinally 
superior to the spine, under the left lobe of the liver just left of the mid-line and ends opposite 
the lower border of the fourth lumber vertebra, by dividing into the right and left common 
iliac arteries. (Figure 2.1) 
 
 
 
Figure 2.1 Anatomy of the abdominal aorta, its location and the arterial branches arise from it1 
 
 
                                                           
1
  anatomytopics.wordpress.com 
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The abdominal aorta gives off visceral and parietal branches which feed the surrounding 
organs ie, liver kidneys, spine, pelvis etc. The first visceral branch of the abdominal aorta is 
the celiac artery which arises anteriorly off the abdominal aorta. It bifurcates approximately 
1-3cm from its origin. Its left branch gives off the left gastric artery and splenic artery and the 
right branch is the common hepatic artery. The Superior Mesenteric Artery (SMA) arises just 
distal to the celiac artery, from the anterior surface of the abdominal aorta. After approx 1cm 
from its origin the SMA diverts inferiorly. It then branches and feeds the jejunum, ileum, 
cecum, ascending colon and segments of the pancreas and duodenum. Just below the origin 
of the SMA, the renal arteries arise laterally off the abdominal aorta. The right renal artery is 
usually slightly superior to the left renal artery. The renal arteries feed the right and left 
kidneys respectively. Approx 3 cm below the SMA and inferior to the renal arteries, the 
Inferior Mesenteric Artery (IMA) arises from the anterior surface of the abdominal aorta. 
This feed the descending and sigmoid colon as well as the rectum. (Zweiebel, 2005; Martini, 
2009; Tortora, 2002) 
The aorta bifurcates at the fourth lumber vertebra into the left and right common iliac arteries. 
The right common iliac is longer than the left as it travel more obliquely across the abdomen 
to the right lower extremity. The common iliac arteries divide into the internal and external 
iliac arteries. The internal iliac artery feeds the pelvic region and the external iliac artery 
becomes the common femoral artery which feeds the lower extremity. (Figure 2.2) 
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Figure 2.2 A closer view of the abdominal aorta and its branches including the iliacs2 
 
The aorta is responsible for the supplying the oxygenated blood that is expelled from the left 
ventricle of the heart around the body. Its wall structure which is discussed below, allows the 
aorta to expand when the blood enters from the heart by the stretching of the elastic fibers. 
The blood is then pushed down and out if the aorta around the body, as the elastic fibers 
recoil. 
 
 
 
 
 
 
 
                                                           
2
  webanatomy.net/anatomy 
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2.2 Structure of the arterial wall 
 
The wall of the aorta is made up of three different layers, a) the intima (inner layer) which 
consists of endothelial cells, b) the media (thick, middle layer) which consists mainly of 
elastic fibers and c) the adventitia (thin, outer layer) made of collagen. The wall has a high 
density of elastic fibers, making it very resilient and able to withstand the pressure changes 
during the cardiac cycle. As the heart contracts it expels a large amount (74 millilitres) of 
blood into the aorta. In response to the hearts contraction the pressure in the aorta rises, the 
aorta’s elastic fibres expand and accommodate the large amount of blood expelled by the 
heart. During ventricular diastole, the pressure drops in the aorta, the elastic fibres recoil and 
the aorta is returned to its normal size. (Grabowski, 2002) (Figure 2.3) 
 
 
 
Figure 2.3 An illustration of the arterial wall and its three layers in a cross section view3 
 
 
 
 
 
                                                           
3
  journals.cambridge.org 
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2.3 Aneurysms: 
An aneurysm is defined as a localized dilation of an artery by approx 50% as compared with 
the expected normal diameter of the vessel. It usually is the result of the breakdown of elastin 
and collagen in the media and adventitia of the arterial wall, with loss of smooth muscle and 
thinning of the medial layer (Lopez-Candales, 1997).  
There are two types of aneurysm, true or false.  
 
2.3.1  A true aneurysm 
A true aneurysm involves the dilation of all three layers of the arterial wall: the intima, the 
media and the adventitia. (Figure 3.1) 
There are two forms of true aneurysm, these are: 
 Fusiform aneurysm  
 Saccular aneurysm 
 
2.3.1.1 Fusiform aneurysm: 
As the name implies, the aneurysm is spindle shaped. The weakness is often along an 
extended section of the aorta and involves the entire circumference of the artery. The 
weakened portion appears as a generally symmetrical bulge, the length of which can vary. 
(Figure 3.1) 
 
2.3.1.2 Saccular aneurysm: 
This is a pouch or sac like outgrowth from one side of the artery, occurring particularly at 
bifurcation points. Thrombotic debris is often present in the lumen of the aneurismal sac. It is 
usually caused by trauma or as a result of a penetrating ulcer. (Figure 3.1) 
 
2.3.2 False aneurysm (pseudoaneuysm)  
Unlike a true aneurysm, this type of aneurysm does not involve the vessel wall. It consists of 
a collection of blood, held around the vessel by connective tissue. (Figure 3.1) 
False aneurysms may arise following traumatic damage to the wall. False aneurysm results in 
a slowly expanding blood-filled cavity. The cavity may rupture or thrombose. (Figure 2.4) 
(Kumer , 2009;  Zweiebel, 2005; Fox, 2004; Martini, 2009) 
 15 
 
Figure 2.4 Aneurysm types, an illustration of true and false aneurysms4 
 
 
 
 
 
 
 
 
 
 
 
 
                                                           
4
  columbia-stmarys.org 
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2.4 Epidemiology of Abdominal Aortic Aneurysms: 
AAA is an incidental medical condition with a high mortality. The pathogenesis of AAA’s 
are not well understood and appear complex and multifactorial. Weakening of the aortic wall 
forming a balloon type sac nearly twice its normal diameter can enlarge and eventually 
rupture (Kumer, 2009). Enlargement of a AAA is due to remodelling of the parietal 
extracellular matrix, particularly to collagen and elastin metabolism (Ailawadi , 2003) 
 
 
 
Figure 2.5 Stages of aneurysmal degeneration5. 
 
The schematic diagram (Figure 2.5) depicts the evolution of an aortic aneurysm. The early 
stages of aneurysmal degeneration are characterized by destructive changes in the connective 
tissue of the aortic wall by a reduction in collagen production and degradation of elastin, 
which promotes dilatation. In time, aneurysm growth occurs through a gradual variation 
between connective tissue (collagen) repair and degradation and the risk of rupture begins to 
rise. Large AAA’s are characterized by more extensive connective tissue (collagen) 
degradation, a more rapid rate of expansion and an accelerating risk of rupture (Thompson, 
1999).  
                                                           
5
  Thompson RW, Baxter BT, 1999 
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The incidence of AAA in men aged between 65 -75 years is 3.9% and 0.7% in women 
(Derubertis 2007; Cho , 2009). AAA usually presents in women who are at an older stage of 
life compared to men (Dillavou, 2006; Brown, 2003)and the growth rate of female AAA’s is 
faster than males (Solberg 2005; Dillavou, 2006).  
The incidence of AAA in Caucasians is much greater than in African and Asian communities 
(Spark , 2001; Hobbs , 2003; Salem, 2009;  LaMorte, 1995). One such study compared all 
races and found the incidence of AAA to be extremely low in Asians and Hispanic, very low 
in Native Americans and African Americans and extremely high in Caucasians (Kent, 2010). 
 The pathogenesis of AAA is unclear. However it is thought that an increase in certain matrix 
metalloproteinases (MMP’s) is involved. MMP are proteins which are involved in the 
breakdown of extracellular matrix in normal physiological processes. A localized increase in 
MMP-8 and -9 levels is a potential pathway for collagen breakdown and has been implicated 
in expansion and rupture of AAA (Kajimoto, 2009; Wilson, 2006). Transcription factors such 
as nuclear factor kappaB (NF κb) which regulate transcription of MMP’s and E-twentysix 
(ETS) with regulates expression of MMP’s are also elevated in patients with AAA (69).  
Studies have shown that the size and growth rates of an aneurysm are significant risks of 
rupture and are associated with high mortality rates (Multicentre Aneurysm Screening Study 
Lancet, 2002; Ogata 2005; Forsdahl, 2009; UK Small Aneurysm Trial, 1999; Heller, 2000; 
Lederle, 2002; Kniemeyer, 2000; Wanhainen, 2005; Zarins, 2006). 
A growth of 1cm or more in 12 months is significant (Ballard, 2000; UK Small Aneurysm 
Trial, 2002). The growth rate of aneurysms increases as they expand. The growth rate of an 
aneurysm at 5cm is 70% faster than an AAA of 4cm (Brady, 2004).  
Rupture of an AAA is a tear in the aortic wall, which occurs due to the weakening of the 
aneurismal wall. The rupture of an AAA is a traumatic and possibly fatal event. The aorta is 
the largest artery in the body origination at the heart and supplying the rest of the body with 
blood. The pressure within the aorta is very high and this leads to excessive and rapid 
bleeding into the retroperitoneal space on rupture, which in turn leads to shock and possible 
death (Beard, 2010).  The size of an aneurysm at risk of rupture is 6cm in males and 5cm in 
females (UK Small Aneurysm Trial, 1999; Dillavou, 2006). The risk of rupture is 3 to 4 times 
higher in females than in males (UK Small Aneurysm Trial, 2002; Dillavou, 2006; UK Small 
Aneurysm Trial, 1999). 
Iliac artery and popliteal artery aneurysms can also be identified with the presence of an 
AAA. Iliac aneurysm occurance is usually associated with AAA’s. An iliac aneurysm is 
diagnosed at a diameter of greater than 1.2cm. They are usually quite large, 4cm and greater 
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but at 3cm their risk of rupture is significant. Popliteal artery aneurysms are the most 
common peripheral aneuryms. Approximately 35-40% of popliteal aneurysms occur with the 
presence of an AAA. The normal diameter of a popliteal artery is 0.5cm. When a popliteal 
aneurysm reaches 2cm, elective surgery is considered (Beard, 2010).  
 
Due to the popliteal artery’s continued stretching with the movement of the leg, the presence 
of thrombus in the aneurysm poses as a high risk for emboli. ‘Acute blue toe syndrome’ is a 
side effect of proximal aneurysms which include the abdomen, iliac, femoral and popliteal. 
This is due to emboli from a proximal aneurysm travelling down the limb and occluding the 
arterial vessels of the toe, which can result in limb damage. (Beard, 2010; Kremkau, 2001).  
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2.5 Treatment of AAA’s   
AAA’s are generally asymptomatic and are usually diagnosed as incidental findings during 
physical examinations for other conditions. The treatment of AAA varies depending on the 
size of the AAA and the risk factors of the individual patient. 
 
2.5.1 Medical Therapy 
 
At present there are no pharmacological treatments available to prevent AAA formation, 
growth and rupture. However, treating cardiovascular risk factors has been shown to prevent 
AAA’s or reduce the progression of an already existing AAA (Beard,  2010).  
When treating the risk factors there are conflicting arguments whether statins are beneficial in 
slowing the growth of AAA’s. Statins are generally used to lower cholesterol by inhibiting 
the enzyme involved in the synthesis of cholesterol in the liver. Studies have reported the use 
of statins to reduce the inflammatory response of macrophages, T lymphocytes and MMP and 
thus reducing AAA progression (Schouten, 2006; Luan, 2003; Kajimoto, 2009). Other studies 
show that lipid lowering drug treatments can delay growth in small AAA’s (Schlosser, 2008). 
While others report that the use of statins, do not help in reducing AAA growth or changes in 
AAA wall composition (Fergusion 2010; Forsdahl 2009, Hurks,2010). 
 
2.5.2 Surgery  
 
Surgery is the only treatment for AAA’s, however no benefit has been shown for elective 
AAA repair procedures on AAA’s of less than 5cm. (UK Small Aneurysm Trial, 2004; 
Lederle 2002; Brown 2008). In AAA’s over 5.5cm elective surgery is usually the preferred 
method of choice (Choke, 2009).  
With the risk of rupture increased at 5.5cm, elective repair surgery has been recommended 
for males with an aneurysm of 5cm or greater (Brown, 2003; Ballard, 2000; Zarins, 2006). 
This procedure prevents the incidence of aneurysm rupture and prolongs life (Rigberg, 2006). 
The mortality of elective repair of screened AAA’s is 3%, somewhat lower than the repair of 
incidental aneurysm repair of 9% (Earnshaw, 2004). Due to more elective surgery being 
performed the incidence of emergent ruptured aneurysm surgery has fallen (Greenhalgh, 
2004) as well as the mortality associated with emergency surgery which is 65-85% of patients 
(Multicentre Aneurysm Screening Study Lancet, 2002, UK Small Aneurysm Trial , 1999; 
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Heller, 2000; Lederle, 2002; Kniemeyer, 2000; Ogata, 2005; Wanhainen, 2005). Open repair 
and endovascular AAA repair (EVAR) procedures in the treatment of AAA are expensive. 
However the cost of emergency repair is double that of elective surgery (Kent, 2004). 
 
2.5.2.1 Procedure for open AAA repair 
 
AAA repair involves proximal and distal anastomoses, so a transperitoneal, longitudinal 
incision is usually the method used. An incision is made in the posterior parietal peritoneum 
to reveal the aneurysm. The common iliac arteries are exposed in preparation for clamping. 
Once the iliacs and the proximal aorta are clamped the aneurysm sac is opened. The lumen of 
the AAA usually contains thrombus, which has to be removed. Once the sac is clear of 
thrombus a synthetic Dacron graft is sutured into place. (Dacron grafts are manufactured 
coated with protein (collagen/albumin) to reduce blood loss and antibiotics to prevent graft 
infection). In the majority of cases a simple tube graft can be inserted but if the iliac arteries 
are involved then a bifurcation graft maybe used. The limbs of the graft can be anastomosed 
to the iliac or femoral arteries. Once haemostasis is secured the aneurismal sac is closed over. 
(www.emedicine.medscape.com) 
 
Open repair even though it is invasive, has been shown to be a successful and effective 
procedure with good graft durability. (Figure 2.6) 
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Figure 2.6 Diagram of an open AAA Repair6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                           
6
  yalemedical group.org 
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2.5.2.2 Procedure for Endovacular aneurysm repair (EVAR): 
This is a minimally invasive technique. In general, it requires the proximal neck of the AAA 
to be relatively straight and between 15 and 30mm in length. Also the iliac arteries need to be 
7mm in size for delivery of the device into the aorta.  
 
Small groin incisions are made to expose the femoral arteries and a self-expanding stent-graft 
(special fabric supported by a rigid structure) is inserted via guide wires and catheters into the 
aortic aneurysm. Usually a modular stent is used, it consists of two pieces one being the main 
trunk of the graft with an ipsilateral limb and the other being the contralateral limb. Both iliac 
arteries are used in the passage of such a stent. Confirmation of stent positioning above and 
below the aneurysm is made by angiography before deployment of the stent and hooks are 
used to attach the stent to the proximal and distal areas of fixation. The stent-graft is anchored 
to a normal part of the patient’s aorta, preventing it from moving. Deployment of the graft 
can be by a self expanding mechanism or balloon expansion, using angiography. Once the 
main trunk and ipsilateral limb are deployed and the contralateral gate in the main trunk is 
open, the contralateral limb is introduced by another guidewire. Deployment of the 
contralateral limb is by retrograde cannulation of the contralateral limb gate of the main 
trunk. The stent-graft is flexible and conforms to the patient’s anatomy, allowing blood to 
flow through it into the iliac arteries and seals off the aneurysm. Angiography is also used to 
ensure the aneurysm is excluded and that correct landing points have been achieved to 
prevent endoleak. The aneurysm sac will shrink over time and be excluded from arterial 
pressure (Beard, 2010; www.medterms.com; Katzen, 2005). (Figures 2.7 and 2.8) 
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Figure 2.7 Example of the stent-grafts used in EVAR7 
 
                                                           
7
  Scientific-analysis.com/medical -technology 
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Figure 2.8 Diagram of an Endovascular Aneurysm Repair (EVAR)8 
 
 
The EVAR procedure is more preferable than open repair, even though both the open repair 
and EVAR in the 2 to 4 years follow up reports are comparable (Peterson, 2007; Faizer 
2007). 
 
The mortality rate for EVAR is 5% compared to 8.3% for open repair (Moore, 2007; 
Peterson, 2007) and its post 5 year freedom from rupture is 93% and AAA related death is 
92% (Zarins, 2006).  Procedure times, blood loss, length of stay in intensive care and hospital 
stay are reduced for EVAR compared to open repair (Moore, 2007; Peterson, 2007). The 
EVAR procedure is more beneficial for unstable, elderly patients as it can be conducted 
under local anaesthesia (Acosta, 2006; Dillovua, 2006; Moore, 2007; Harris, 2005). However 
EVAR is a relatively new procedure, a long term outcome has not been proven. There have 
been cases where conversion to an open repair was performed on post EVAR patients 
(Peterson, 2007).  
 
                                                           
8
  yalemedical group.org 
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Not every patient is suitable for EVAR due to the size and course of their AAA and 
peripheral arteries, therefore careful selection is important before such a procedure. 
 Females have an increased mortality rate than men and do not survive rupture or surgical 
treatment very well (Semmens, 2000; Solberg 2005; Acosta, 2006, UK Small Aneurysm 
Trial;, 1999; Dillavou 2006; Katz, 1997; Harthun, 2008). Females have a 40% increased risk 
of dying during or after surgical repair (Katz ,1997). Surgery is much more traumatic on 
females than on males, this is due to longer hospital stays caused by their older age and 
presence of other co morbid conditions (Dillavou, 2006). In females, open repair is the 
method of choice as Endovascular Aneurysm Repair (EVAR) can be more complicated due 
to short proximal aneurysm necks and small iliac arteries (Acosta, 2006; Katzen, 2005). 
 
As AAA’s are asymptomatic in nature, screening is the best method of detecting and 
preventing AAA reaching the point of rupture. Due to the high mortality rate associated with 
ruptured AAA, screening is an effective, cost saving exercise. 
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3. Literature Review on Abdominal Aortic Aneurysms 
 
3.1 Introduction of Abdominal Aortic Aneurysms: 
An abdominal aortic aneurysm (AAA) is defined as a localised dilation of the aorta, usually 
below the renal arteries (infra-renal) which measures 3cm or greater in diameter or a diameter 
of 1.5 in comparsion to the proximal aorta (Fleming, 2005). AAA is a common and 
potentially life threatening condition which predominately affects men of 65 years and older 
(Katz 1997,  Ȃlund , 2008). 
A normal proximal abdominal aorta has a diameter of 1.75cm in men and 1.3cm in women 
(G.J Tortora, 2002; Goldberg , 1993). Studies have suggested that a non-aneurysmal infra-
renal diameter measuring >2.6cm may indicate the possible risk of a AAA formation, 
particularly dyslipidaemia (Forsdahl, 2009; Devaraj 2008). 
AAA’s are asymptomatic and are rarely detected until rupture. The incidence of 
asymptomatic AAA’s appear to be 0.8% at age 50 and increase to 6% at age 65 in males 
(Vardulaki, 2000). Rupture is defined as extravasion of blood or hematoma outside the AAA.  
(Acosata Hardiman Index, 2006). One third of untreated AAA’s will rupture. Ruptured 
AAA’s (rAAA) are responsible for 1.3% of all deaths among males between the ages of 65–
85 years. (Sakalihasan, 2005; UK Small Aneurysm Study, 1999).  
Ruptured AAA’s require emergency surgery and have an associated mortality rate of 65–85% 
half of which occur prior to surgery. It is more preferable to perform elective surgery on 
AAA’s before they rupture. The mortality rate for elective AAA repair is 0%-9%, a rate 
significantly lower than emergency repair surgery. (Multicentre, Aneurysm Screening Study 
Lancet 2002; UK Small Aneurysm Trial, 1999; Heller, 2000; Lederle, 2002; Kniemeyer, 
2000; Ogata, 2005; Wanhainen, 2005). 
AAA’s are mainly asymptomatic; therefore screening is required for diagnosis. Once 
diagnosed, the aneurysm size and growth can be kept under surveillance to assess the risk of 
rupture.  An AAA of 5.5 - 6cm is considered a risk of rupture. Once it is considered a risk, 
elective surgery is recommended. Previous studies have shown that screening for AAA’s is 
cost effective and can reduce the mortality rate. (Multicentre, Aneurysm Screening Study 
Lancet, 2002 & BJM 2002; Norman 2006; UK Small Aneurysm Trail, 1999 & 2002; 
Forsdahl, 2009). 
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3.2 Risk Factors for AAA development: 
Abdominal Aortic aneurysm is a complex vascular condition with no one specific cause for 
its development. Risk factors for AAA formation include male sex, age, smoking, family 
history as well as atherosclerosis. (Cole, 2001; Vardulaki, 2000). 
 
3.2.1 Gender: 
Male sex is the most predominent risk factor. AAA’s occur up to 5 times more in men than in 
women (Vardulaki, 2000). With the incidence of AAA in women thought to be 0.7% 
compared to that of men, which is 3.9% (Cho, 2009; Derubertis, 2007). However, the growth 
rate of AAA’s is significantly higher in females than in males (Solberg, 2005; Dillavou, 
2006).Women have smaller anatomies compared to men therefore the risk of rupture in 
females is at a smaller AAA size compared to males (Harthun, 2008; Katz, 1997; Forsdahl, 
2009; Brown,2003, UK Small Aneurys Trial, 1999).  
 
AAA’s in males are reported at 65 years and older, where as AAA’s in women occur in a 
later age group (75-80 years) (Harthun, 2008). When women are diagnosed with AAA they 
usually have other co morbid conditions, making treatment of their AAA complicated. The 
risk of AAA in females compared to males appears to be similar to their risk for 
cardiovascular disease. Females are protected from such disease in their middle ages due to 
the high level of oestrogen in their system pre-menopause. A lab based study documented a 
decrease in AAA formation in male rats when they were treated with oestrogen, thus like 
other cardiovascular diseases, oestrogen may protect females from AAA formation until later 
in life (Cho, 2009) 
Astrand et al reported that stress on the male abdominal aortic wall increases with age and its 
response to compensatory thickening is insufficient, unlike that of the female abdominal aorta 
(Astrand, 2005). 
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3.2.2 Age: 
 
The incidence of AAA increases with age from 0.8% in males at the age of 50 years to 6% of 
those aged 65 years (Vardulaki, 2000). The risk of AAA formation and rupture increases with 
age, with the incidence peaking at 65-70 years in males (Vardulaki, 2000; Lederle, 2009; 
Alcorn 1996; Ȃlund, Mani, Wanhainen, 2008), where as in women it is at 70-80years 
(Derubertis 2007; Dillavou 2006). AAA usually presents in women who are at an older stage 
of life compared to men (Dillavou 2006; Brown 2003) 
 
 
3.2.3 Smoking: 
 
Smoking appears to be one of the strongest independent risk factors for AAA formation and 
growth. (Lee, 1997; Ogata, 2005; Wanhainen, 2005; J.F. Blanchard, 2000). Current smoking 
and duration of smoking are the most prevalent (Wanhainen, 2005; Ogata 2005; Wilmink, 
1999; Bergoeing, 2007). 
Life- time male smokers are 2.5 times more likely to present with an AAA than non smoking 
males (UK Small Aneurysm Trial, 2002). Patients who have been previous smokers have 
reduced risk of death compared to current smokers (UK Small Aneurysm Trial, 2002). 
Previous smoking still poses a risk, but at a lower incidence of 1.5 times that of non smokers 
(Vardulaki, 2000). A study by Lee et al of current and recent ex-smokers the likelihood of 
AAA was 3 times greater than ex-smokers of 5 years and more, than those who never smoked 
(Lee, 1997). Smoking has also been proven to be the biggest risk predictor for AAA in 
females (DeRubertis, 2007). Studies have shown that smoking increases growth rates of 
AAA’s by 15-20% and therefore increasing the risk of rupture (UK Small Aneurysm Trial, 
1999; Lee 1997; Brady 2004). 
 
The link between smoking and its strong association with AAA formation and growth 
appears unknown, however some studies suggest serum cotinine, a nicotine metabolite 
increases growth rate of AAA’s (Wilmink, 1999). It is also thought that some components of 
smoking may inhibit the active site of α 1 –antitrypsin, leading to the degradation of elastin in 
the aortic wall by proteolytic enzymes. (Lee, 1997; Wilmink, 1999). 
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The association of smoking and AAA formation and progression is much more pronounced 
than the association of smoking with coronary artery disease (CAD) (Lederle, 2003). Long 
term smokers have a higher possibility of death from AAA’s than CAD. This suggests that 
AAA formation is not independantly caused by the atheriosclerotic process. (Lederle, 2003; 
Lee, 1997; Wilmink, 1999). 
 
 
3.2.4 Atherosclerosis: 
 
Atherosclerosis is associated with damage to the endothelial lining and lipid deposits in the 
tunica media. Increased lipid levels in the blood initiates the formation of atherosclerosis. 
Atherosclerosis formation occurs with breakdown of the endothelial wall, promoting 
aggregation of platelets and also attracting phagocytes. Cholesterol and triglycerides collect 
at the injury site of the inner layer of the arterial wall. Macrophages arrive at the site due to 
the inflammatory process. Contact with platelets, lipids and other components of blood 
stimulate smooth muscle cells and collagen fibres   in the arterial wall to proliferate 
abnormally. This occurs due to low levels of apolipoprotein- E (ApoE), which transports lipid 
in the blood and are quickly absorbed by body tissues or by high levels of low density 
lipoprotein which is slowly absorbed by the body. In response to this there is a build up of 
lipids and formation of atherosclerosis which causes a narrowing in the arterial wall and 
disturbance to the blood flow. (Martini, 2009; Tortora, 2002) (Figure 3.3) 
 
The inflammatory process of atherosclerosis is linked with the AAA formation, enlargement 
and rupture cycle. (Sandford,2007, Daugherty 2002, Kaschina, 2009). One study implicates 
the inflammatory response as a potential cause of aneurysm rupture (Choke, 2009).  Matrix 
metallopeptidase 9 (MMP9) is an enzyme when secreted presents a pathway for collagen 
degradation, AAA expansion and rupture. (Wilson, 2006) However, this does not prove that 
atherosclerosis and an inflammatory response is a direct cause of AAA. A recent study 
examined the diabetic association of AAA and reports atherosclerosis as an associated feature 
and not a causative factor (Shantikumer, 2010). (Ref Figure 3.1) 
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Figure 3.1 The inflammatory process involved in the formation of atherosclerosis9 
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3.2.5 Hypertension and its association with AAA: 
 
Hypertension (HTN) has been shown to pose a risk of AAA formation (Lee, 1997). There are 
conflicting studies which argue that HTN is risk of rupture rather than formation and growth 
of an AAA. While other studies have reported that there is no relationship between HTN and 
formation of AAA or increased expansion rates of existing AAA’s (Vardulaki, 2000; 
Wanhainen, 2005; Brady, 2004). 
 
HTN has been shown to be associated with AAA rupture due to its haemodynamic stress 
effect and its involvement in the up regulation of transcription factors (Shiraya, 2006; 
Astrand, 2005). The haemodynamic burden on the aortic wall depends on the mean blood 
pressure. An elevated burden is constantly putting pressure on the ever weakening 
aneurismal section causing the AAA to enlarge (UK Trial, 1999). In large and ruptured 
AAA’s the wall stress at maximal systolic blood pressure is considerably higher than in 
small AAA’s (Truijers, 2007; UK  Small AneurysmTrial 1999; Choke, 2009; Astrand, 2005) 
which shows the association between HTN and rupture. (See Appendix 4 for different ranges 
of blood pressure) 
 
 
3.2.6 The role of high cholesterol in AAA formation: 
 
Elevated LDL cholesterol, total cholesterol and triglycerides have been recorded in patients 
with AAA (Wanhainen, 2005; Lee 1997). Studies have shown that cholesterol alone does not 
cause aortic enlargement (Kobayashi, 2004; Lindholt, 2001; Ferguson, 2010). Significant 
association of plasma LDL and small aortic aneurysms has been shown (Hobbs, 2003). One 
study has shown that small LDL size is an independent risk factor for AAA (Rizzo, 2009).  
However, Golledge et al claims there is no association between LDL and AAA, but there is 
consistent association between low HDL and small AAA (Golledge, 2010). HDL has anti 
inflammatory and antioxidant properties and a low HDL level reduces its preventive 
properties and therefore may lead to inflammation of the abdominal aorta (Golledge, 2010). 
(See Appendix 5 for normal value of cholesterol) 
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3.2.7 Relationship of Diabetes Mellitus and AAA: 
 
Most studies have shown the inverse effect of Diabetes Mellitus (DM) on AAA formation 
and growth. (DeRubertis, 2007; Vega de Cengina, 2006; Brady 2004; Shantikumar, 2010). 
One study has shown the association of the circulating marker of the glycation pathway, 
carboxymethyllysine (CML) and discovered levels of CML to be lower in patients with 
diabetes and AAA compared to patients with AAA and no diabetes (Norman, 2009). Another 
study suggests that hyperglycemia inhibits metalloprotinases (MMP) production, and 
therefore inhibiting MMP activity which is essential in AAA progression (Miyama, 2010). 
This is one explanation of the negative relationship of DM and AAA formation. (Figure 3.2) 
 
 
Figure 3.2 Effect of diabetes on AAA 
 
The above diagram (Figure 3.4) shows the inverse effect of diabetes in AAA expansion. In 
hyperinsulinaemiam, decreased fibrinolysis leads to decreased mural thrombus formation 
which accumulates in an AAA. The less mural thrombus present, prevents the AAA from 
expanding further. 
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Hyperglycaemia causes that arterial wall to stiffen due to an increase in matrix, protein cross-
linking and vainculin positive focal adhesions. Due to this increased wall stiffness the 
aneurysm is unable to expand further.  
The therapeutic agents given to diabetes sufferers, decrease inflammation, MMP levels and 
blood pressure. All of which are heavily involved in the formation and expansion of an AAA. 
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3.3 Screening for AAA: 
Screening is used to detect and diagnose specific population groups for disease before they 
become symptomatic. Its advantage is that a disease caught in its early stages can be treated 
effectively and prevent it from becoming a risk of mortality. The disadvantages of screening 
programmes are the cost of the programme and the stress and anxiety caused to the patient 
once diagnosed. 
 
There are specific guidelines for the feasibility of screening. For a screening programme to be 
effective, the disease involved in the screening programme has to cause a burden on the 
health system due to the serious consequences when well developed. There must be a well 
established method of treatment if the disease is found in its early stages. This early treatment 
needs to be more beneficial than treatment of the disease in its later stages. It is also essential 
that diagnostic and treatment facilities for such a screening programme exists. 
Many studies have been undertaken and have shown the need for screening for AAA in men 
between the ages of 65-74 years. The Multicentre Aneurysm Screening Study (MASS) 
carried out in the United Kingdom was one of the first large screening programmes for AAA. 
It looked at many aspects of screening for AAA, such as incidence, the effect on mortality 
and cost effectiveness of an AAA screening programme. It showed the incidence of AAA in 
males between the ages of 65-74years to be 4.9%. The detection of AAA reduced the risk of 
death in a four year period from 3.3% to 1.9% per 1000.  
 
The high mortality of a ruptured AAA (rAAA) is a major burden on all health systems. A 
large number of screening studies have shown a 50% or more reduction in AAA related 
deaths in screened patients (UK Small Aneurysm Trial, 2002; Norman, 2004; Lindholt , 
2010; Thompson, 2010; Takagi H, Goto, 2010). Mani’s study reported that patients with 
AAA’s detected at a screening programme had a higher survival rate and more opportunity 
for elective surgery, than patients who were selectively scanned in a vascular laboratory 
(Mani, 2009). 
 
Some studies have investigated the likelihood of AAA development years after screening. 
Acosta et al, Vardulaki et al and Thompson et al all claimed that a single scan would be 
enough for men of 65 years of age with a normal aortic diameter, as the development of an 
AAA is highly unlikely in ten years post a normal scan. However, Thompson did find a very 
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small number of patients had a rAAA 8 years post a normal abdominal aortic scan. But this 
number was so small that it did not justify the need for rescreening (Acsota, 2006; Vardulaki, 
2002; Thompson, 2010). 
 
Screening has shown that it can reduce the mortality of a rAAA and the high cost of 
treatment for this potentially fatal disease (Greenhalgh, 2006). A screening programme can 
accurately diagnose a AAA and reduce the incidence of rAAA and emergency surgery by up 
to 75%, while increasing elective repair and reducing AAA specific mortality by 50-67% 
(Heller, 2002;  Lindholt, 2006;  Lindholt, 2008; Lindholt, 2010; Thompson, 2010; Takagi, 
2010). Due to the early diagnosis of AAA during screening, elective repair is more cost 
effective, is shorter and has fewer complications than emergency repair (Lindholt, 2006; 
Multicentre Aneurysm Screening Study 2002; Wanhainen, 2005). 
 
The cost effectiveness of any screening programme is always a point consideration. As 
mentioned above a screening programme for AAA is cost effective as it reduces the high cost 
of emergency repair for ruptured AAA’s. There have also been studies into the cost 
effectiveness in relation to life years gained (LYG) and quality adjusted life years (QALY). 
Four studies have a reported a survival advantage to AAA screening. The addition of life 
years gained has increased due to such screening. Overall the incremental cost for LYG and 
QALY is lower than the recommended, set values considered to be cost effective for this type 
of screening programme (Lindholt , 2008; Schmidt, 2010; Thompson, 2010). 
 
Some argue that one of the disadvantages of AAA screening is the decrease in psychological 
morbidity in patients diagnosed with AAA, as it may cause a permanent source of anxiety 
(Wanhain, 2005). The majority of studies who investigated the mental effects of AAA 
screening showed no ill effects (Multicentre Aneurysm Screening Study 2002; Fleming, 
2005; Brannstorm, 2009; Khaira, 1998). The results of the questionnaire showed that men 
diagnosed with AAA as well as those with normal aortic sizes, had better health or stayed the 
same post screening (Spenser, 2004). 
 
Women are currently not considered for screening for AAA as the prevalence of AAA in 
women is at an older age (approximately ten years older than men) (Dillavou ,2006; Brown 
2003; Scott, 2002). There are still arguments on whether females should also be screened for 
AAA.  Due to women’s small and more complex anatomies it is thought that the risk of 
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rupture in females is at a smaller AAA size compared to males (Harthun, 2008; Katz, 1997; 
Forsdahl, 2009; UK Small Aneurysm Trial, 1999; Brown, 2003). Mean diameter at rupture of 
females is 5cm compared to a mean diameter of rupture in males of 6cm (UK Small 
Aneurysm Trial, 1999; Dillavou, 2006). Surgery should be considered in females with 
AAA’s of a diameter between 4.5-5cm (Scott, 2002). One study recommends females of ≥65 
with confirmed arterial stenosis to be screened as such a condition could be a predictor of 
AAA (Ȃlund, 2008). Another study has recommended screening for women over 65 years of 
age, who smoke and have other cardiovascular disease (DeRubertis, 2007). Many studies 
recommend different guidelines to be set and used in screening females for AAA’ s (Brown, 
2003; UK Small Aneurysm Trial, 1999). Due to the fact that there is a low incidence of 
rupture in females below 75 years of age, screening is not considered to be cost effective 
(Scott, 2002).   
 
The United States Preventive Services Task Force (USPSTF) has recommended the screening 
of all men between the ages of 65-75 years who have ever smoked for AAA disease, due to 
its possible fatality and cost of emergency treatment. (Fleming, 2005).  
Studies in Europe have proven a similar incidence of AAA and increased cost in its treatment 
as in the U.S. especially the MASS study in the United Kingdom. Due to these reports it is 
now accepted that screening is beneficial in saving lives and reducing the expensive costs of 
emergency health care due to ruptured AAA’s.  
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4. Methods of Diagnosis of AAA: 
Most AAA’s are asymptomatic and are usually detected accidentally during physical 
examination. Large AAA’s may be detected clinically by careful palpation or feeling of the 
abdomen, which may reveal an abnormally wide pulsation of the abdominal aorta. In 
overweight people, aneurysms can be very difficult to detect on physical examination. 
Aneurysms on the verge of rupture and that are rapidly enlarging, are often tender. Listening 
with a stethoscope may also reveal a bruit or abnormal sound from turbulence of blood within 
the aneurysm. Symptoms only occur near to or at point of rupture. These include lower 
abdominal, back or testicular pain, nausea and vomiting, feeling of coldness in the legs, 
profuse sweating and hypotension post rupture. (Kumer, 2009;  Warrell, 2010). 
 
An abdominal aortic aneurysm needs diagnostic imaging to be diagnosed and accurately 
measured. The first method of choice is ultrasound as it is non-invasive. Ultrasound has been 
shown to be a reliable and a cost effective method in the diagnosis of AAA. 
 
4.1 Physics of Ultrasound 
 
4.1.1 Sound Waves: 
 
Sound waves consist of mechanical vibrations of particles within a medium. The vibration of 
one particle transmits a vibration to the next particle and so the wave moves through the 
medium. The transmission of a sound wave occurs at a fixed speed which is determined by 
the density and elasticity of the medium. Velocity of ultrasound depends on the medium it 
penetrates. (See appendix number 1 for velocity of ultrasound in different mediums) The rate 
at which the particle vibrates is called the frequency. 
Sound waves have a longitudinal, sinusoidal waveform which varies from high pressure 
(compression) to low pressure (rarefraction). The waveform has characteristic properties such 
as wavelength (λ), frequency (F) and period (T). 
The wavelength (λ) is the distance between identical points in a cycle. 
The frequency (f) is the number of cycles occurring in one second. Units are Hertz (Hz) 
The period (T) is the length of time it takes for one cycle to occur. Unit are microseconds 
(µs). (Figure 4.1) 
Ultrasound is a cyclic sound wave of a frequency greater than human hearing (20 kHz). 
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4.1.2 Frequency 
 
The frequency of a sound wave is the speed of which the particle vibrates. This is measured 
in hertz and is the number of cycles per second (Kremkau, 2001).  
The frequency range of Ultrasound is above 20kHz. Diagnostic ultrasound has a frequency 
greater than 1MHz. Frequency is very important, higher frequencies give better resolution 
(clearer, crisper image) but there is greater attenuation.  
 
 
Figure 4.1 A sound waveform10 
 
4.1.3. Attenuation 
 
Attenuation is the reduction of the intensity of an ultrasound beam as it passes through a 
medium. It is a major limitation in ultrasound scanning. It is very important to use an 
appropriate frequency for the anatomical region being scanned. Higher frequencies are best 
as they give a more resolved image. However due to the high attenuation associated with high 
frequencies, depth of penetration is reduced. As frequency increases, attenuation increases 
and the depth of penetration decreases.  
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Ultrasound is altered by the type of tissue it penetrates. At boundaries between different 
tissues with different acoustic impedances, the ultrasound beam will be reflected, scattered, 
refracted or absorbed depending on the tissue. (See appendix number 3 of acoustic 
impedances of body tissues)  
 
Attenuation mechanisms are: 
1. Absorption 
2. Scattering 
3. Reflection 
4. Beam divergence  
5. Refraction 
Absorption and scattering are the two main causes for attenuation. Eighty percent of the 
attenuation of the sound wave in soft tissue is caused by absorption resulting in the energy of 
the ultrasound wave being converted into heat.  Attenuation is measured in decibels per 
centimetre of tissue and is expressed by the attenuation coefficient of the specific tissue.  The 
higher the attenuation coefficient for the specified tissue, the more attenuated the ultrasound 
wave is. Bone has a very high attenuation coefficient and therefore severely limits beam 
transmission. (See appendix number 2 for attenuation coefficients of specific tissues). The 
degree of attenuation also depends on the frequency of the ultrasound wave and the distance 
travelled by that wave. The higher the frequency of a wave, the greater the attenuation 
therefore the depth of tissue penetration is limited. The lower frequency of a wave, the lower 
the tissue attenuation and the greater the depth of penetration.   
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Figure 4.2 A graph showing the impact of ultrasound frequency on attenuation11 
 
To compensate for attenuation and low signal amplitude, gain is used. This boosts the 
attenuated echo signal. If the overall gain is increased there is uniform amplification of the 
returning echo which will increase the brightness of the overall image and produce noise 
which can distort the image. Time gain compensation (TGC) is preferred as it can be adjusted 
for the weaker signals returning from deeper structures boosting their amplitude to that equal 
amplitudes are displayed on the entire image. 
 
4.1.4 Reflection and Scattering: 
Reflection is determined largely by the angle of incidence. If the angle of incidence is 90 
degrees to the medium the reflected echo will be perpendicular to the transmitted beam. If the 
angle of incidence is < 90 degrees to the medium the resultant wave will be deflected away 
from the transducer at an angle equal to the angle of incidence but in the opposite direction 
(angle of reflection). When this occurs, the returning echo signal is weakened. 
Ultrasound is reflected at smooth surfaces between two media for example the diaphragm or 
walls of a major vessel.  For reflection to occur, the wavelength of the ultrasound wave must 
be smaller than the reflective structure. At interfaces that are not perfectly smooth the 
ultrasound wave is scattered. Scattering occurs when the wavelength of the ultrasound wave 
is greater than the size of the reflective structure (e.g., red blood cells). The echo’s received 
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from scattering are usually weaker than reflected echo’s. Not all of the ultrasound beam is 
reflected or scattered some of the beam will generally be transmitted into the next medium. 
 
 
Figure 4.3 Reflection of Ultrasound12 
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4.1.5 Refraction: 
Refraction is the change in the direction of a sound beam as it crosses from one medium to 
the next. It depends on the velocity of ultrasound in both media, which is determined by the 
impedence of the media. If the sound beam crosses from a medium with lower ultrasound 
velocity into a medium of higher ultrasound velocity the angle of transmission will be greater 
than the angle of incidence and visa versa. This is based on Snell’s Law, which states that the 
ratio of the sines of the angles of incidence and of refraction is a constant that depends on the 
media. Tissues like bone and fat cause extensive refraction and image distortion.  
 
 
 
Snells Law 
 
 
Figure 4.4 Snells Law13 
 
n1 Sin θ1 = n2 Sin θ2 
 
 
 
                                                           
13
  tiaonline.org 
 43 
4.1.6 Ultrasound Transducer 
 
The transducer is both the source and the receiver of ultrasound waves this is due to the 
rectangular piezoelectric elements which make up the transducer. The piezoelectric effect is 
the conversion electrical energy into ultrasound (mechanical) energy and then conversion the 
ultrasound energy back into electrical energy. When the piezoelectric crystals are excited 
they vibrate and send out waves, the combination of these waves makes up the ultrasound 
beam. They also detect the returning echo’s covert them back into electrical energy which 
can then be processed to produce the ultrasound image. 
 
 
Figure 4.5 Diagram of the operation of an ultrasound transducer14 
 
 
There are many types of transducers such as linear, curvilinear, phased and vector arrays. 
In this study the curvilinear transducer is only transducer relevant, so this is the only probe 
that will to be dealt with in this review. 
The curvilinear probe has a curved surface. It is made up of approximately 200 rectangular 
piezoelectric elements. Voltage is applied to the elements in groups of about 5-20 elements. 
The first group will send out its pulse, it will then wait to receive its returning echo before the 
next group of elements is excited. This means the beam will sweep from one side of the 
transducer to the other side to form the image. Several beam sweeps per sec are needed to 
provide a real time image.(Figure 4.5) 
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Because of the curved construction, the pulses travel out in different directions. This provides 
a real-time sector type image. Curvilinear transducers usually have a frequency ranging from 
3.5MHz to 5MHz. Therefore they are the transducer of choice when scanning deep regions 
(greater than 5cm and more below the skin) like the abdomen and provide highly resolved 
images at such depths. (Figure 4.6) 
 
 
Figure 4.6 Direction of ultrasound beams in a curvilinear transducer15 
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4.1.7 B-mode imaging 
 
B-mode is a two dimensional (brightness modulated) grey-scale image. It is comprised of a 
number of grey dots. The brightness of each dot is a representation of the amplitude of the 
signal received. In grey scale imaging, solid structures (bone) appear white and fluid (blood) 
appears black, with white having the strongest intensity and black having the lowest intensity.  
Short ultrasound pulses are sent into the body at a fixed rate call pulse repetition frequency 
(PRF). The transducer will then wait for the echoes from that pulse to be reflected back 
before it transmits the next ultrasound wave. Echoes are reflected back from areas where 
there is an acoustic impedence between tissues. These reflected echoes will be amplified and 
processed for display on the monitor. The vertical position of each bright dot is 
determined by the time delay from pulse transmission to return of the echo, and the 
horizontal position by the location of the receiving transducer element. The varying 
shades of grey give information on the variation of the textures of the organs 
interrogated. Each echo position gives depth and brightness information.  
Depth of each echo is determined by the range equation. 
 
 
 
d = distance to reflector where echo was produced (mm) 
c = speed of sound (1540m/sec) 
T = time travelled by pulse from the transducer to the reflector and back to the transducer 
again (sec) 
 
A number of beam lines are used to construct a B-mode image, this is usually approximately 
100 to 200 pulses. 
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Figure 4.7 Block diagram of a B-mode scanner16 
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4.1.8 Artifacts associated with B mode: 
 
1. Reverberation. 
This occurs due to a strong reflector ie vessel wall or needle stick, which causes multiple 
artificial reflectors below the reflector. Each subsequent reflection is weaker than the prior 
reflection  
 
2. Mirror imaging 
This is a form of reverberation where a structure at one side of a strong reflector is also 
present on the other side too. It leads to false positioning of structures. It can be caused by the 
diaphragm. 
 
3. Shadowing. 
This is due to a strong reflector or absorber in the scanned field. The attenuation at this point 
cannot be compensated by time gain control (TGC). A shadow occurs beyond the structure 
obscuring imaging of the field below the reflector. It occurs in areas of bone and calcified 
plaque.  
 
When screening for AAA’s B-mode is usually the only ultrasound mode used. Pulse Doppler 
would only be used to verify an artery and colour Doppler would not be used due to flash 
artefact.  However in the majority of vascular scans pulse wave Doppler and colour Doppler 
are both used. In this thesis we will have brief look at both these modes. 
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4.1.9  Doppler mode: 
 
Ultrasound Doppler equipment is used to evaluate blood flow by using sound waves to image 
and measure the velocity of blood flow, which in turn gives functional information about a 
blood vessel. This functional information is based on a slight change in frequency of the 
ultrasound beam after it reflects off a moving object e.g blood cells, corpuscles. 
It is based on the Doppler principle. The transducer emits a beam with a frequency (fo) and 
receives an echo of a different frequency (fr). The frequency difference is due to echoes being 
picked up by moving scatterers such as red blood cells. 
The Doppler shift frequency (fd) is the difference between the transmitted and reflected 
frequencies. 
 
 
 
 
fd  = Doppler shift 
fr = reflected frequency 
fo = transmitted frequency 
V = flow velocity 
 θ = Doppler angle 
c = speed of sound (1540m/sec) 
 
There are two types of Doppler, continuous wave and pulse wave Doppler. 
In continuous wave Doppler the transducer is continuously transmitting and receiving 
ultrasound pulses. This form of Doppler gives no directional information and therefore angle 
independent.  
Pulsed Doppler sends ultrasound pulses repetitively to a target at a particular range. A 
localised sample volume, which is controlled by the operator, is placed within the target at a 
fixed depth. The sample volume is repeatedly interrogated by transmitted pulses from the 
transducer. The detected Doppler signal is produced by the reflected echo pulses received. 
Each sample of the Doppler shift is filtered and added to other samples to produce a 
waveform. This waveform is plotted as a function of time (horizontal axis) and frequency 
shift (vertical axis) to provide a two-dimensional spectral display (Zweiebel, 2005; Hykes, 
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1992; Kremkau , 2001). Pulsed wave Doppler gives directional information and is angle 
dependent. 
Doppler angle (θ) is extremely important and depends on Cosine. Accurate Doppler shifts of 
flow are angle dependant. The error is greater at larger angles then in smaller angles due to 
the Cosine. If θ is 0 than Cosine θ is 1 and this would only occur if the blood is flowing 
directly at the transducer. At large angles Doppler shifts decease as well as the systems 
sensitivity. At angles less than 30° the sound no longer enters the blood but bounces off the 
vessel wall.  
Flow speed calculations are not reliable at angles of greater than 60°. For an accurate 
measurement of flow the Doppler angle must be correct for the angle of the blood flowing. 
There will always be errors at angles of less than 60°. However they are small and acceptable. 
 For blood flow calculation it is recommended that the operator only use angles between 40° 
and 60°, with the angle line in a parallel position to the blood flow.  
 
 
 
Figure 4.8 Effect of the Doppler angle in the sonogram. (A) higher-frequency Doppler signal is obtained if the 
beam is aligned more to the direction of flow. In the diagram, beam (A) is more ali)gned than (B) and produces 
higher-frequency Doppler signals. The beam/flow angle at (C) is almost 90° and there is a very poor Doppler 
signal. The flow at (D) is away from the beam and there is a negative signal.17 
                                                           
17
  centrus.com 
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4.1.10 Colour Doppler mode 
 
Colour Doppler imaging extends the use of the pulse-echo imaging principle to include 
Doppler-shifted echoes that indicate blood flow or tissue movement. Colour flow image data 
are superimposed on B-mode data from stationary structures to obtain a composite image.  
Colour coding is due to the mean Doppler shift along a scan line. Eight to ten pulses are used 
per scan line which will in turn increase frames rate. Approx 4-32 frames per sec are 
generated in a colour flow image. This increase in frame rate will decrease the resolution of 
the image. 
 
The mean Doppler shift per scan line is designated a hue or shade. This gives direction and 
flow velocity information. Red and blue are the opposing directional colours with green 
indicating turbulent flow. A light hue indicates high velocity flow and a dark hue indicates 
low velocity flow. 
Due to colour Doppler being based on a mean Doppler shift and with an unknown angle of 
interrogation colour Doppler is not accurate enough to use as a single diagnostic tool.  It must 
be incorporated with pulse wave Doppler. ( Zweiebel, 2005; Hykes, 1992; Kremkau, 2001) 
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Figure 4.9 Pulse-wave and Colour Doppler image18 
 
 
4.1.11 Image Optimisation for vascular ultrasound imaging 
 
To ensure the best image is obtained, controls on the ultrasound machine can be changed to 
suit the area of interest depending on depth and location of the organ.  
 
 
 
 
 
 
 
 
 
 
                                                           
18
  diagnostica.com 
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4.2. Limitations of Ultrasound 
Major limitations with ultrasound is that it cannot travel through bone, air or gas. In AAA 
scanning is the presence of bowel gas and obesity can obscure the imaging. Patients who are 
obese are more difficult to image as the sound wave attenuates as it passes deeper into the 
body, therefore leading to suboptimal imaging and inaccurate measurements being obtained.   
Intestinal gases also prevent visualization of deeper structures. Calcification of the artery can 
also obscure the image as the beam may not be able to penetrate the artery, therefore not 
giving a clear view of the arterial wall. Tortuousity can also impede the imaging, making it 
difficult to follow the course artery. The scan is also operator dependant, inter observer error 
can lead to inaccurate measurements of AAA and therefore maybe misleading in AAA 
growth on follow up scans. Performing an inter observer error test is vital to assess the error 
of measurement between fellow technologists in a scan centre. Detailed knowledge of image 
optimization (the max amount of depth and width required to view the aorta etc) is also 
necessary to attain a clear image and accurate measurements. Therefore it is important that a 
full train vascular technologist performs the scanning in a screening setting. It is vital the 
machine settings are correct for the scan being performed. To ensure the best possible image 
is obtained. 
 
 
4.3 Ultrasound for AAA diagnosis 
 
In a clinical setting Ultrasound is said to be the most practical, non-invasive and inexpensive 
modality in screening for and surveillance of AAA , with a sensitivity of 98.9% and 
specificity of 99.9% (Sprouse, 2004; Lindholt 1998; Lederle, 2000; Fleming, 2005; 
Multicentre Aneurysm Screening, 2002). Ultrasound can reliably image the aorta in 99% of 
patients (Lindholt, 1999), however it is highly operator dependent (Mirza, 2010). 
Real-time ultrasound provides the examiner with a two-dimensional greys-scale image of the 
abdominal organs and vasculature. It is possible to image anormalies of arterial location and 
arterial course as well as pathologically dilated segments. Information can be gathered about 
the extent of aneurysms from cross-sectional measurements in different planes and these 
values can also be used in relevant follow-up examinations. 
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Significant portions of the abdominal aorta are not visualised on emergency due to non 
fasting patients and the presence of bowel gas etc. This rate is higher than reported for fasting 
patients receiving elective ultrasound for evaluations of their aortas. 
Ultrasound is not very accurate in determining the presence of a leak from an aneurysm. A 
RAAA can be indicated by the presence of free fluid in potential abdominal spaces. However, 
contrast enhanced CT is required for confirmation. 
 
Duplex and colour flow Doppler ultrasound examinations of the abdominal cavity are highly 
dependent on the clear display of the tissues and vascular structure provided by B-mode 
ultrasound. B-mode is often used on its own in abdominal ultrasound to detect arteriosclerotic 
wall plaques and aneurysms of the abdominal aorta and pelvic arteries. 
The more echogenic structures within the vascular lumen can be recognised due to their 
strong ultrasound reflection when compared to blood. This makes sonographic imaging of 
morphological wall changes of varying pathology possible as they occur in various types of 
aneurysm, including walls deposits (plaques) and also parietal thrombi. 
Doppler mode and colour flow are not necessary tools in AAA diagnosis but can be helpful in 
identifying the iliac arteries. (Figure 4.10) 
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Figure 4.10 Transverse B-mode image of an AAA, with an anterior posterior measurement. 
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Figure 4.11 Longitudinal B-mode image of an AAA 
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4.4 Computed Tomography (CT) 
 
Computed Tomography is based on the principle of attenuation. It is composed of a large ring 
containing x-ray sources and arrays of detectors which rotate around the patient. Multiple x-
ray fan-beam sources sends out ionizing radiation into the patient’s body. Attenuation occurs 
and the array detectors then process the beams post attenuation. The level of attenuation 
depends on the density of the medium (e.g. muscle is more dense than blood). The arrays 
mathematically construct the image by numbering the attenuations detected. The larger the 
number, the more dense the medium and the lighter the shading on the image.   
This method happens in 4 steps: 
Step 1: The tube and detectors are rotated at a constant speed. 
Step 2: The x-ray tube is energised and data collected for 360 degrees. 
Step 3: The tube and detectors slow down and come to a stop. 
Step 4: The table and patient are indexed to the next scanning position.  
(Figure 4.111 and 4.12)  
 
CT gives a digital, transverse (transaxial) image. It is composed of slices of cross-section 
views. Computed tomography scanning creates superb images of the brain, bone, lung and 
soft tissue and it doesn't allow information from irrelevant locations to enter the acquired 
data. 
 
Contrast-enhanced CT is widely used in the preprocedural imaging of AAA’s. The 3-D 
images obtained from the CT are also used in the planning of endovascular procedures. It 
involves the use of CT and the injection of a high speed contrast media. This procedure is 
used in the assessment of the arterial tree, as the contrast agent highlights a narrowing in an 
artery. In AAA imaging it shows the dilation of the aorta, it allows the accurate measurement 
of the diameter of the aneurismal section and the length of the vessel involved. 
The advantage of contrast-enhanced CT imaging is the accurate assessment of the blood 
vessels, giving detail to the location and length of the affected vessel. However there are 
many disadvantages to CT contrast imaging: 
1. It is highly invasive. 
2.  The patient may be allergic to the iodine contrast agent. 
3. During CT imaging the patient is exposed to high doses of ionizing radiation. 
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Figure 4.12 Components of a CT machine19 
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  rst.gsfc.nasa.gov 
 58 
 
Figure 4.13 CT image of an AAA 20 
The arrow is pointing at the AAA. 
                                                           
20
  medscape.com 
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4.5 Ultrasound verse CT 
 
Ultrasound is the method of choice in screening and AAA surveillance as it avoids high doses 
of radiation and minimises costs compared to computed tomography (CT). (Sandford 2006; 
Pages 2001; Collins 2007; Sprouse,2004). 
 
CT has been a widely used tool in the diagnosis and detection of AAA. However it is an 
expensive, time consuming method with high doses of radiation being given to the patient. 
Ultrasound is a quick, inexpensive and non invasive method which is more suitable in 
diagnosis and screening for AAA (Multicentre Aneurysm Screening Study, 2002; Sprouse, 
2003). CT is gold standard preoperatively as it accurately measures the diameter of the 
proximal neck of aorta, diameter and length of the aneurysm, diameter of the aorta just before 
the bifurcation, length from the aneurysm to the bifurcation and diameters and length of the 
iliacs and femoral arteries. The use of CT provides accurate configuration of stent grafts for 
the individual’s anatomy. (Kim, 2010) 
 
Ultrasound has also been shown to be the method of choice for measuring maximum AAA 
diameter. Ultrasound and CT do not always take the measurement on the same axis (Sprouse, 
2003). CT takes the max cross-sectional area at any point, ultrasound takes the largest 
diameter in anteroposterior or transverse aspects (Sprouse, 2004).CT takes an oblique cut of 
the aneurysm to measure the max diameter, if the AAA in angulated more than 25 °, the 
diameter measured by the CT will be over estimated. (Sprouse, 2003 & 2004). Ultrasound is 
less effected by a tortuous vessel as the probe can be tilted to get a more accurate cross 
sectional area. (Sprouse, 2003 & 2004).  
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5. Method: 
 
5.1 Programme Set Up 
 
An AAA and cardiovascular screening programme was set up in the Vascular Diagnostic 
Unit  in Connolly Hospital over a two year period.  
The General Practitioners (GP’s) in the catchment area of the hospital were asked to identify 
patients on their databases who fit the criteria of this study. (Please see inclusion criteria 
below). Once the vascular lab received the patient lists from the GP’s the lab and I 
coordinated the appointment schedule. I was assigned the project manager for this pilot 
screening study. All participants were invited to attend the vascular unit for AAA and 
cardiovascular risk factor screening. Participants were advised to fast for a minimum of 
twelve hours pre-examination, to enable a fasting lipid and triglyceride profile to be obtained 
by finger prick blood test and also to reduce bowel gas thereby improving ultrasound imaging 
of the aorta.  
At the end of every screening session I collected the data obtained and correlated the database 
to achieve the final results. 
 
 
 
5.2 Ethics 
 
 Ethical approval for the proposed screening programme was granted and informed consent 
was obtained from all patients in the study. 
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5.3 Population Criteria 
 
5.3.1 Inclusion criteria 
The inclusion criteria were male sex in the age group 55-75 years.  
 
5.3.2 Exclusion criteria  
The exclusion criteria include participants with terminal medical conditions or previous 
history of AAA. Females are also excluded from the study. 
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5.4 Screening Examinations 
 
The assessment consists of two parts: clinical risk assessment with a fasting lipid profile, and 
a duplex ultrasound of the aorta. 
 
 
5.4.1 Clinical risk assessment with a fasting lipid profile 
A full cardiovascular history was obtained by a clinical nurse specialist. The participant’s 
height and weight was measured to determine their body mass index (BMI). BMI equals a 
person's weight in pounds divided by their height in inches squared, multiplied by 703. 
Normal BMI was defined as between 18 and 25 overweight was >25 and morbidly obese was 
>30 (WHO, 2000). Their blood pressure reading was recorded. Normal blood pressure values 
were defined as less that 140mmHg systolic and 90mHg diastolic. Finger prick tests were 
also performed for total cholesterol, triglyceride and glucose estimation using Cholestech 
LDX® System (Cholestech, California). Normal cholesterol valves, including high density 
lipoprotein (HDL) and low density lipoprotein (LDL), as well as triglyceride values were 
defined per standard guidelines. 
A fasting serum total cholesterol of 5.0mm/mol or greater was classed as 
hypercholesterolaemia. An abnormal glucose was defined as a fasting serum glucose of 
7.0mm/mol or greater (WHO, 2006). All abnormal finger prick test were confirmed using 
standard blood samples.  
The nurse specialist advised on the risks of developing symptomatic athero-thrombosis with 
the participants. Advice was also give on lifestyle changes which would help them prevent or 
control their risk factors. 
 
 
5.4.2 Duplex ultrasound of the aorta 
 
A duplex ultrasound was performed according to the protocols of the Society for Vascular 
Technology of Great Britain and Ireland (Ref) by a team of accredited vascular technologists, 
including myself. 
A General Electric Logic 9 ultrasound machine with a curvilinear 3.5 MHz transducer was 
used. (Figure 5.1 and 5.2) 
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Figure 5.1 GE Logiq 9 Ultrasound Machine21 
 
 
 
Figure 5.2 Curvilinear Transducer22 
                                                           
21
  all-medical.co.uk 
22
  all-medical.co.uk 
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The machine was pre set for abdominal scanning. Calibration is done automatically by the 
machine once it is powered on. The machine was serviced regularly and tested using a 
phantom by the technical staff from GE. 
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5.4.2.1 B-mode control settings in Abdominal scanning 
 
Overall gain is usually be adjusted throughout the scan. It is increased for deep vessels such 
as the aorta. An appropriate gain is when the lumen of the vessel appears black and the walls 
white. 
Time gain compensation (TGC) toggle knobs should be gently sloping which compensates 
more for the greater attenuation at deeper structures. The slope is usually seen beside the B-
mode image. 
Focus control sets the focal zone which is the arrow beside the B-mode image. This arrow 
should always be at or just below the level of interest. This provides the best image resolution 
at this point. 
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 5.5 Protocol for screening for abdominal aortic aneurysm screening 
 
Participant should be fasting for at least 10-12 hours prior to screening. 
The participant was placed in a supine position with knees slightly bent and arms relaxed at 
their sides, to ensure the abdominal muscles are relaxed. 
Normal respiration was usually sufficient, but in cases where bowel gas obscures the image 
the patient was asked to take a deep breath in and as they breathe out the technologist puts 
pressure on the probe to try dispersing the gas and improve the image. 
A 3MHz curvilinear probe was used for maximum depth. 
A clear water-based gel was applied to the abdomen to help the transducer make secure 
contact with the body and eliminate air pockets between the transducer and the skin. 
The transducer was placed in a transverse plane, just left of the participants mid line above 
the umbilicus. 
The abdominal aorta was located. 
In the transverse plane, the abdominal aorta displays a large, pulsatile, round, anechoic lumen 
surrounded by bright, echogenic, muscular walls. It is positioned anterior to the spine, just 
left of the midline. The renal arteries can be seen to branch from the lateral walls of the aorta. 
In the longitudinal plane, the abdominal aorta appears as a large, echo free, tubular structure 
running superiorly to inferiorly through the retroperitoneum of the abdominal cavity. The 
celiac and superior mesenteric arteries arise from the anterior wall of the aorta.  
The inferior vena cava was seen on the left of the image. It appears as a less pulsatile, 
generally triangular structure. 
The transducer was moved distally until the aortic bifurcation into the right and left common 
iliac arteries was seen. 
The transducer was then slowly moved proximally, along the length of the abdominal aorta as 
far the coeliac axis and superior mesenteric artery (SMA) origin. The size and calibre of the 
vessel were examined. 
The widest point of the aorta was located by slowly sweeping the transducer proximally and 
distally. 
Only a slight pressure application was applied with the transducer to prevent compression of 
the aorta and in accurate measurements being obtained also in concern of a precipitating aorta 
rupture. 
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The aorta may be tortuous not only in an anterior posterior plane, but also in mediolateral 
plane, causing a significant deviation from the normal course. 
Once the largest diameter of the aorta was identified, the image playback function was used 
to freeze the image in systole. The aorta was imaged along its length and the largest diameter 
located. The measurement was taken in systole measuring leading edge to leading edge both 
in transverse and longitudinal section. The renal arteries are located and diameter of the infa-
renal and supra-renal segments are measured. 
The anterior posterior diameter of the aorta was measured using calipers. 
Making sure when measuring the outer wall to outer wall diameter and that the correct focal 
zone was set at the correct level. 
Keeping the transducer in a transverse plane and the aorta was measured at the level of the 
renal arteries. 
Remaining in transverse mode, the transducer was moved distally and the aorta was measured 
at the most distal point, just above the level of the bifurcation into the common iliac arteries. 
The transducer was rotated into a longitudinal plane and the length of the aneurysm was 
estimated. The aneurysm may be longer than the capacity of the image display and this can 
lead to error in measurement. 
Remaining in a longitudinal plane, the infra-aneurysmal section of aorta was estimated, 
between the distal extent of the aneurysm and the iliac bifurcation. 
Once an aneurysm was detected, it was measured in transverse along its length when frozen 
in systole to achieve the largest diameter. It was also measured in longitudinal to assess the 
length of the aneurysm. 
When an aneurysm was detected the machine was unfrozen and we looked for any signs of 
thrombus within the aneurysm. 
The appearance of any thrombus for fissures or dissection was examined. 
The aneurysm was examined for signs of inflammation. Inflammatory aneurysms may be 
identified by the presence of a low echogenic region surrounding the immediate area outside 
the bright echogenic artery wall. 
The iliac arteries were then imaged for aneurysmal disease by tilting the probe to the left and 
right of the participant.   
If an AAA was detected the participants iliac, femoral and popliteal arteries were also 
assessed for the presence of an aneurysm. 
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5.6 Follow-up Criteria 
 
Follow up was defined as per international guidelines (Fleming, 2005) (see table below). The 
normal abdominal aortic measurement is defined as less than 3cms. A normal iliac artery 
measurement is defined as l cm. 
 
 
 
 
 
 
Follow-up 
less than 3cm Discharged 
3-4cm 12 months follow-up scan 
4-4.5cm 6 months follow-up scan 
4.5-5.4 3 months follow-up scan and surgical consult 
5.5cm and greater Elective surgery 
 
Table 5.1 Follow up criteria chart 
 
Any participant identified with an AAA of 3cm or greater had a consult with a vascular 
surgeon on the day of diagnosis. The results of the risk profile and recommendations for 
treatment are referred back to the family practitioner for follow-up. 
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6. Data 
 
6.1 Participant demographics 
 
A total of 1414 male participants between the ages of 55-75 were invited to participate in the 
screening programme. A total of 904 (64%) participants accepted the invitation. Of these, 568 
(63%) were aged between 55 and 64 years and 336 (37%) were aged between 65 and 75 
years. The mean age was 62 years and the standard deviation was 5.37. 
 
 
Figure 6.1 Age range of the participants 
 
 
6.2 Risk Factor Assessment: 
 
6.2.1 Previous Medical history: 
When questioned by the nurse it emerged that 137 participants had been treated for ischemic 
heart disease (IHD) by means of a stent or coronary artery bypass, 21 participants had a 
history of a transient ischemic attack (TIA) or cardiovascular attack (CVA) and 9 participants 
had diagnosed peripherial vascular disease. Aspirin had been prescribed to 222 of the 
participants for its antiplatelet effect and warfarin had been prescribed to 32 of the 
participants for its anticoagulant effect. 
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6.2.2 Body mass index  
 
Five hundred and seventy three participants agreed to have their body mass index measured, 
16% (93/573) were morbidly obese (BMI > 30) and 64% (367/573) were overweight. Overall 
80% of the participants whose BMI was calculated were overweight. 
 
 
6.2.3 Smoking 
 
A total of 11% (104/904) of participants were smokers. There were 6% (58/904) ex-smokers 
and 82% had never smoked. 
 
 
6.2.4 Hypertension 
 
Six participants did not have their blood pressure recorded due to an ill fitting cuff. 
Of the 898 who had their blood pressure checked, 33% (294/898) of participants had a 
previous history of HTN and 68% of these still had an isolated elevated blood pressure, 
despite having been previously been prescribed an anti-hypertensive. Of participants with no 
previous history of hypertension, 31% (278/898) had a single elevated blood pressure 
measure during the screening process. (ρ < 0.00001) 
 
 
6.2.5 Hypercholesterolemia  
 
Of the 904 participants tested for hypercholesterolemia, 26% (234/904) had a previous 
history of elevated cholesterol, with 165 (70%) of these being inadequately controlled. In 
participants with no previous history, 33% (302/904) of these were newly diagnosed with 
hypercholesterolemia, of these 71% of the newly diagnosed where between the ages of 55-64 
years of age. 
From our results 33% (303/904) of the screened population had an HDL level of less than 
1mmol/l and 41% (374/904) had a LDL level of greater than 3mmol/l. (ρ < 0.01) 
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6.2.6 Diabetes Mellitus (DM)  
 
The results in screening for DM were, 6% (55/904) of participants had an elevated fasting 
blood glucose level of greater than 7 mm/mol, 49% (27/55) of these had a previous history of 
DM and had a poor sugar control. Of the participants with no previous history, 3% (28/904) 
undetected elevated glucose levels in excess of 7mmol/l. ( ρ < 0.02) 
 
 
 
Table 6.2 Risk Factor Assessment 
   
From the above graph the participants with a previous history of HTN, hypercholesterolaemia 
and DM are compared to the participants who never had a history for these risk factors but on 
the day of screening their levels were above the normal average. (Table 6.2) 
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Table 6.3 Uncontrolled Treatment of Risk Factors 
 
The above table shows the number of participants who were treated for a previously 
diagnosed risk factor, but on the day of the screening they had elevated levels for their treated 
risk factor. 
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6.3 Abdominal aortic Aneurysms 
 
All participants underwent an ultrasound of their aorta. Two aortas were not successfully 
imaged due to morbid obesity and these patients declined further attempts of imaging. 
Of all of the scanned patients the incidence of AAA was found to be 1.9% (17). An incidence 
of 0.6% of the men aged between 55-64years had an AAA and 4.2% of the men aged 65-75 
years had an AAA(p <0.01).  
 
The aneurysm sizes ranged from 3.0cm to 5.8cm. Three AAA’s were detected in the 55-64 
years age, the size of each were 3.8, 3.4 and 3.09cm. Fourteen AAA’s were detected in the 
males between 65-75 years. Six of these patients had a measurement of between 3.0-3.9cm, 
five had an AAA measurement of 4.0-4.9cm, 2 had an AAA measurement of 5.1 and 5.3cms 
and one patient had a measurement of 5.8cm. 
 
 
Aneurysm Size by Age
3
3.5
4
4.5
5
5.5
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50 55 60 65 70 75
 
Table 6.4 Aneurysm Size 
 
Of the 17 participants who were diagnosed with a AAA, two of these had an iliac aneurysm. 
Both patients with the iliac aneurysms were aged over 65. No femoral aneurysm was 
detected.  
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For the purpose of analysis the participants were then separated in to two groups, Group A 
had a normal abdominal aortic measurement (887 patients). Group B had an AAA of 3cm or 
greater diagnosed (17 patients). 
The risk factors of both groups were compared 
 
Group A: participants with a normal abdominal aortic measurement (n = 887) 
• 54% had an elevated blood pressure reading 
• 38% had elevated total cholesterol 
• 32% had a HDL reading of less than 1.0mm/mol 
• 6% had an elevated glucose level 
• 12%  smoked and 6% were ex smokers  
• 16%% were morbidly obese 
 
 
Group B: participants with an abdominal aortic aneurysm (n = 17) 
• 58% had an elevated blood pressure reading 
• 17% had elevated total cholesterol 
• 65% had a HDL reading of less than 1.0mm/mol 
• 5% had an elevated glucose level 
• None claimed to smoke, however there were two ex smokers in the 17 diagnosed 
• 42% were morbidly obese 
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Table 6.5 Risk Factor comparison 
 
All the participants with a diagnosis of an AAA were followed up according to the criteria 
given in Figure 25. The participant with an AAA measuring 5.8 was seen by a vascular 
surgeon, sent for a CT and elective surgery was performed. The operation was successful and 
the patient is good health. 
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7 Discussion: 
 
Many abdominal aortic aneurysm screening programmes have proven to be successful in the 
diagnosis of asymptomatic AAA’s and have helped to reduce the related mortality of AAA 
(Multicentre Aneurysm Screening Study, 2002; Adam, 1997; Powell, 2003; Lederle, 2000; 
Kent, 2010). AAA screening has shown to reduce all cause mortality by 5 per 1000 (Takagi, 
2010). Diagnosis leads to adjustments in cardiovascular risk factors which can in turn lower 
other cardiovascular deaths (Mastracci, 2007). 
 
This AAA screening study was one of the first of its kind to be held in Ireland. Males 
between the ages of 55-75 years were screened for AAA unlike most other programmes 
which only included males between the ages of 65-75 years of age (Multicentre Aneurysm 
Screening Study, 1999; Lindholt, 2005; Thompson, 2010, Montreil, 2008). The risk factors in 
these younger men were also examined. Screening males of younger than 65 years has not 
been thought to be beneficial as males younger than 65 years would need to be rescanned in 
ten years (Crow, 2001; Ashton, 2002). The study showed the incidence of AAA in Irish 
males between 65-75 years to be 4.2% comparable with other worldwide AAA screening 
studies (Multicentre Aneurysm Screening Study, 1999; Lindholt, 1996; Jamrozik, 2000). The 
incidence of AAA in the males between 55-64 years was found to be significantly lower 
(0.6%) which also concur with other studies who have found the incidence of AAA is most 
prevalent between 65 and 75 years (Kent, 2010) (ρ > 0.01). This would suggest that screening 
males between the ages of 65-75 in Ireland is justified but the screening of men between 55-
65years was not justified (ρ < 0.01). 
 
The cost effectiveness of such programmes has also been shown by a considerable number of 
programmes from around the globe. This included cost incurred by the health system and cost 
of life years gained and quality adjust life years (Multicentre Aneurysm Screening Study, 
1999; Schmidt, 2010; Thompson, 2010; Ehlers, 2009; Montreil, 2008). AAA screening has 
reduced the frequency of emergency surgeries by up to 75%. The cost of elective surgery has 
proved to be less than emergent procedures. And the cost of life-years gain has also reduced 
since the introduction of AAA screening in the late 90’s (Multicentre Aneurysm Screening 
Study, 1999;  Lindholt, 2006). The real cost effectiveness of AAA screening was beyond the 
scope of this study. With the necessary service, machines and expertise in place, additional 
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use of facilities can provide a screening service without a significant burden on the economic 
budget of a health organisation. 
 
From this screening programme, 17 AAA were diagnosed. Compared to other screening 
studies our finding of 4.2% of our screened population aged between 65 and 75years 
concurred well. These findings suggest that screening for AAA’s in Irish males of 65 and 
over would be worthwhile and beneficial to our health system. The incidence of AAA 
detected by the screening programme in males aged 55-65 years of age was found to be 0.6% 
(ρ > 0.01) which compares to other findings who do not believe screening these younger men 
to be beneficial or cost effective (Crow, 2001; Aston, 2002).  All of the patients diagnosed 
with AAA from this study were followed-up as per international guidelines (Fleming, 2005). 
However, on the day of screening, all the AAA patients had a consult with the department’s 
vascular surgeon. This reassured the patients and reduced any anxiety caused by their new 
diagnosis.  
 
A screening programme for AAA will never prevent all AAA ruptures as the initial screening 
attendance rate will never be 100% and not all patients with diagnosed AAA will co operate 
fully with the follow-up procedures given to them. 
 
 
Due to the age of this programmes population it was decided to take the opportunity to screen 
for cardiovascular risk factors. Cardiovascular disease (CVD) causes a major burden on 
health care systems worldwide and is the main cause of death under 75 years of age. CVD 
accounts for 36% of all deaths in Ireland, 48% of all deaths across Europe and 42% of all 
deaths in the United States of America (USA). It is estimated that cardiovascular disease 
costs the European Union (EU) 192 billion euro yearly (www.croi.ie; www.heartstats.org; 
www.apps.who.int; www.healingwithnutrition.com). 
 
There is a high incidence of cardiovascular disease in Ireland.  It is believed that 80% of heart 
disease can be prevented if the risk factors for CVD are diagnosed early and adequately 
treated. This study screened for the main risk factors which included BMI, smoking, HTN, 
cholesterol and DM.
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Obesity has always being a major risk factor in CVD. However in recent years the levels of 
obesity are increasing worldwide as children are heading into pre adulthood already over 
weight. This is due to an increased calorie intake and a decrease in physical activity. In 2007, 
a study of the Irish population showed 31% had a BMI of >30kg/m2 and 80% had a BMI of 
>25kg/m2.  In 2003 statistics from the United Kingdom showed 23.6% had a BMI of 
>30kg/m2 and 66% had a BMI of >25kg/m2. In the same year the USA statistics reported 
42.3% had a BMI of >30kg/m2 and 79% had BMI of > 25kg/m2 (www.apps.who.int).  From 
this study 331 men refused to have their BMI calculated for reasons assumed due to it being a 
psychologically sensitive matter. For the other 573 who did agree, 16% had a BMI of > 
30kg/m2 and 64% had a BMI of >25kg/m2.  Comparing the elevated BMI results from this 
study 80% of the participants were overweight, which compare well to other Irish and 
worldwide studies. In AAA, an increased waist circumference is associated with a large 
number of AAA’s above 4cm (Golledge, 2007). Obesity is a major determining factor on the 
mortality and morbidity post surgery and reduces the success of treatment. It causes an 
increase in wound complications and operating times. In the study, the relationship between 
BMI and AAA is not clearly defined due to the small number of AAA patients diagnosed, 
even though 42% of the 17 new diagnosed patients were overweight. However there is no 
doubt that increased BMI is becoming a major burden on health systems as both the younger 
and older generations are now suffering from obesity where only a few decades ago it was 
only a problem arising in adults.  Ireland has one of the highest rates in childhood obesity in 
the world. The “Growing Up in Ireland” study in 2009 found 1 in 4 nine year olds being 
overweight or obese, another survey suggests the level of obesity in young Irish people 
between 16 and 24 years of age has tripled in between 1990-2000. 
 
Smoking is a major, independent risk factor for CVD. It appears that smoking is more 
strongly related to AAA development and growth than in CAD (Lederle, 2003). The 
association between smoking an AAA development and progression is relatively unclear. 
There have been studies which suggest that the components of smoking effect the arterial 
wall and therefore correlate with AAA formation and growth.(Lee,1997; Wilmink, 1999) 
However, this is not a clear and confirmed conclusion and further studies need to be carried 
out to support this research. From a European Commission health survey published in 2009 
(www.ec.europa.eu), approximately one third of the European population smoke and from 
the WHO database of males (www.who.int/en) between 2002 and 2005, 27.5%  in the US 
were smokers, 28% of the  UK  population smoked and 24.2% of Irish smoked.  In this study 
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only 11% were current smokers. Compared to the smoking statistics this figure seems 
significantly low. It is likely that the incidence was possibly higher but unreported by the 
patient population. This may reflect the negative social aspects of smoking in Ireland in the 
aftermath of the smoking ban, which was introduced in 2004. 
 
Hypertension has been shown as a risk in the formation of AAA’s. It is a significant risk for 
rupture on large AAA’s as it puts added haemodynamic stress on the ever weakening arterial 
wall (Lee, 1997; Wainhainen, 2005; Truijers,  2007; Choke, 2009). When rupture occurs 
there is increased blood loss into the abdominal activity a due to HTN and this significantly 
increases the risk of morbidity. 
 
In 2009 it was estimated that 44% of Europeans suffer from hypertension 
(www.centrus.com). It is thought that over half the Irish population aged 50 or greater are 
affected by HTN with only a third being treated for their elevated blood pressure (Awareness 
Initiative Highlights Ireland’s Biggest Killer. Prolog May 2008). In this study, 33% had a 
previous history with 68% of those on treatment, but with an elevated blood pressure reading 
at the time of screening, 31% had never been diagnosed with hypertension but were found to 
have an elevated blood pressure reading during screening. From our results the single blood 
pressure reading taken at the time of screening gave 64% with elevated blood pressure, this is 
14% greater than the estimated 50% of the Irish population suffering from HTN.  However 
these values maybe falsely elevated, so these patients were referred back to the GP for further 
investigation and monitoring.  
 
When screening for hypertension, one must consider the number of factors that may give a 
false elevated measurement. The two main reasons are cuff size and ‘white coat syndrome’. 
Often in a screening situation a full range of cuff sizes are not available. The measurement of 
blood pressure needs to be accurate, so the size of the cuff and its correct placement is vital. 
Six patients did not have their blood pressure recorded in this study due an ill fitting cuff. The 
cuff available was of normal adult size but was not big enough to be placed around some 
patient’s arms so their blood pressure could not be measured accurately. If a normal adult 
sized cuff is used in an obese person it artificially overestimates the blood pressure reading 
significantly.  
Elevated blood pressure can also be due to “white coat syndrome”. This is usually at a 
subconscious level where the patient feels relaxed going to the doctor, however their ‘fight or 
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flight’ response is activated once they arrive and their blood pressure is abnormally elevated. 
Often blood pressure readings at home can be normal but appear elevated at the doctor’s 
clinic setting. Ambulatory blood pressure monitoring can be used to differentiate between 
true hypertension and “white coat syndrome”. The patient is required to wear the monitor for 
over a 24 hours period. A blood pressure measurement will be taken half hourly during the 
day and hourly at night. This gives an overall view of the patient’s blood pressure in their 
normal everyday life. 
 
It has been documented that Ireland has the lowest rates for HTN testing in a GP setting in 
Europe. From this study 68% of participants diagnosed and treated for HTN still had elevated 
blood pressure readings. This is a major problem which needs to be dealt with. It could be 
due to poor GP follow up, with the patient on too low a dose or on a type of medication that 
is not strong enough to control their HTN. However it could also be due to poor medication 
compliance by the patient. It is hoped that the GP will follow up these patients and ensure 
they are on adequate treatment and their HTN is controlled. 
 
Cholesterol appears to be a contributing factor to AAA formation and growth as well as being 
a well known cardiovascular risk. It is associated with 56% of all coronary heart diseases. It 
is generally due to heredity factors or poor diet. Approximately 20% of the adult population 
in America suffer from hypercholesterolemia (National Cholesterol Education Program. 
Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults, 1994). A comparison study between Irish and European cardiovascular 
risk factors showed Ireland to be favourable with only 27% having a total cholesterol of 
greater than the target level of 4.5mm/mol (Cooney, 2009). The recommendations for 
cholesterol screening are checks every five years for men of 35 years and over 
(www.uptodate.com). It is preferable to have the patients fasting but nonfasting results can 
also be indicative of hypercholesterolemia (National Cholesterol Education Program. Second 
Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood 
Cholesterol in Adults, 1994; US Preventive Services Task Force. Guide to Clinical 
Preventive Services, 1996; Craig, 2000).  
In this study, 26% of the patients had been diagnosed and treated for hypercholesterolemia of 
these 70% still had an elevated total cholesterol reading. Of the screened population 33% 
were newly diagnosed with hypercholesterolemia. From these results, the percentage of 
participants who had previously being diagnosed with hyperlipidaemia are comparable with 
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the 27% recorded in another study. However, 33% had never been diagnosed with 
hyperlipidaemia but had an elevated level of >5mm/mol. Therefore in this result up to 60% of 
our screened population had a fasting lipid profile of >5mm/mol, which is much larger than 
the other Irish studies recording.  
 
Diabetes Mellitus is characterised by a partial or complete lack of insulin production by the 
body. There are two types of DM. Type 1 is a complete lack of insulin production and the 
only treatment is a regular injection of insulin. Type 2 is a partial lack of insulin in the body 
which is managed by oral medication, diet and exercise programmes. It poses as a major risk 
factor for cardiovascular disease with a 2 to 4 fold increased risk of CVD in patients with 
Type 2 DM. However, it appears to have an inverse effect on AAA formation and growth 
(DeRubertis, 2007; Vega de Cengina, 2006; Shantikumar, 2010). DM diagnosis is increasing 
at an alarming rate due to the increased levels of obesity and lack of exercise in the current 
times. This is a significant problem as there are many side effects linked to DM, the main 
organs affected are the kidneys, eyes, feet and heart. It is estimated that 7.8% Europeans and 
4% of the Irish population suffer from DM, with approximately 50% unaware of their 
condition. In this study 6% of the patients had a previous diagnosis of DM, with 49% of these  
still having a blood reading of >7mm/mol. In those patients who had no history of DM, 3% of 
those presented with an elevated blood sugar level. The levels of DM in this study compared 
well with the European result but is slightly higher than the Irish record.  Diagnosis and 
proper control of such a disease is vital to contain this chronic and life rendering effects on 
the population and keep the financial burden of such a disease low on the health care system. 
For those already diagnosed DM patients it is important that they are educated on their 
disease and the effects of a bad lifestyle. This may help with the control of such a disease and 
reduce its side effects.  
 
This study differs from screening programmes due to its inclusion of a younger age group. In 
the males between 55 and 64 years who had AAA and also being diagnosed with 
cardiovascular risk factors, questions could arise on the possibility of such an early pick up of 
both AAA and the risk factors could also reduce the level of AAA surgery and mortality. A 
long term study is planned to investigate if early pick and treatment of risk factors can halt 
the growth of their AAA in five and ten year periods. However, this is beyond the scope of 
the present study. 
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During this study the patients received lifestyle advice from a clinical nurse specialist. Life 
style is major risk for all cardiovascular disease. In patients diagnosed with risk factors for 
cardiovascular disease it is important to stress that their medication alone does not control 
their condition. Exercise is a very good and simple method of controlling HTN, cholesterol, 
obesity and DM. A recent European survey showed that only 18% of the Irish population 
reported moderate physical activity, with 41% sitting for an average of 4-8 hours daily 
(Euorbarometer Survey on Physical Activity, 2005). Having a healthy lifestyle is also a major 
factor in control of such diseases and can also help the patient to feel better and more vibrant. 
Many people are not well educated on the importance of a healthy lifestyle. It is very 
important that this advice is given as it can make the patients feel more positive and more 
proactive in their own treatment. 
 
Another limitation was we did not note if any of these participants had medical cards as it 
was a free screening programme. In view of our alarming high uncontrolled condition results 
and overall elevated results which compare badly to the national statistics, it maybe due to 
low social economic community of the GP’s, lack of  knowledge on a healthy lifestyle or lack 
of finance which deterred the participants from having regular visits to their GP to monitor 
their risk factors.  
 
In view of the smoking results as a whole the low level of smokers is unbelievable. If the 
study was continued it might be an idea to include an exhaled carbon monoxide exam for a 
true recording of the smokers and non smokers in the group.  
  
This study has proven that AAA screening is beneficial and cost effect in men aged 65-75 
years in Ireland. In the younger group AAA screening did not prove to be beneficial. The 
AAA’s picked up were of very small sizes and these would be picked up at the screening of 
this group at 65 years. The screened population also benefitted from the cardiovascular risk 
factor analysis. It proved the real need for a national cardiovascular screening programme for 
both the younger and older groups. 
 
Such combined screening studies acting as a “one stop shop” where screening for AAA, 
cardiovascular risk factors and a consult are cost effective and worthwhile. Screening for 
multiple factors as a research programme is possible. However, screening for these multiple 
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factors in a clinical setting is not viable or effective as every disease has a precise criteria and 
patient demographics would differ too much.  
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8 Conclusion: 
 
From this study the incidence of AAA in Irish males between the ages of 65-75 years is 
similar to the incidences recorded worldwide. Therefore, screening for AAA is beneficial and 
programmes need to be established to reduce AAA related deaths and would impact the cost 
incurred on emergency medical treatment for AAA’s. However, screening males of 55-64 
years of age for AAA has not been proven to worthwhile or economically viable. 
The incidence of cardiovascular risk factors in Irish males is considerably high. 
Unfortunately, some males who had already been diagnosed and treated for their risk factor 
were not adequately followed up, and their risk factor remaining uncontrolled. This leaves 
these men susceptible to cardiovascular disease despite treatment.  
 
Many Irish men between the ages of 55-75 years appear to have undiagnosed risk factors for 
CVD. This can lead to early disease and possibly a high cardiovascular morbidity and 
mortality rate at an early age. This proves the necessity of screening for cardiovascular risk 
factors at 55 years or younger. It is imperative that once diagnosed and treated, the patient is 
regularly monitored to assess their cardiovascular risk. It is essential to educate the patient on 
treatment compliance and give advice on the lifestyle changes required. This gives the patient 
empowerment in the control of their cardiovascular risk.  
 
Screening for cardiovascular risk factors is not complicated and can easily be incorporated 
into other screening programmes. This would take advantage of the high attendance that 
maybe achieved in screening for other individual medical conditions. 
 
 
 
 
 
 
 
 
 85 
9 Appendix 
   
Medium Ultrasound Speed (m/sec)  
Air 300  
Lung 500  
Fat 1,450  
Brain 1,520  
Muscle 1,580  
Liver 1,550  
Kidney 1,560  
Brain 1,560  
Soft Tissue 1,540  
Bone 4,000  
 
1.  Velocity of Ultrasound in tissue 
 
Body Tissue  
Attenuation Coefficient 
(dB/cm at 1MHz) 
Water 0.002 
Blood 0.18 
Fat 0.63 
Liver 0.5-0.94 
Kidney 1.0  
Muscle 1.3-3.3 
Bone 5.0  
 
2.  Attenuation coefficients of body tissues
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Body Tissue  
Acoustic Impedance 
(106 Rayls)  
Air 0.0004 
Lung 0.18 
Fat 1.34 
Liver 1.65 
Blood 1.65 
Kidney 1.63 
Muscle 1.71 
Bone 7.8 
 
3.  Acoustic impedances of body tissue 
 
 
Top 
number 
(systolic) 
in mm Hg  
   
Bottom 
number 
(diastolic) in 
mm Hg  
Your 
category*  
What to do**  
Below 120  and  Below 80  Normal blood 
pressure  
Maintain or adopt a 
healthy lifestyle.  
120-139  or  80-89  Prehypertension  Maintain or adopt a 
healthy lifestyle.  
140-159  or  90-99  Stage 1 
hypertension  
Maintain or adopt a 
healthy lifestyle. If blood 
pressure goal isn't 
reached in about six 
months, talk to your 
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doctor about taking one 
or more medications.  
160 or more  or  100 or more  Stage 2 
hypertension  
Maintain or adopt a 
healthy lifestyle. Talk to 
your doctor about taking 
more than one 
medication.  
 
4. Blood pressure chart, what the readings mean 
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Total cholesterol 
U.S. and some other 
countries  
Canada and most of 
Europe  
  
Below 200 mg/dL Below 5.2 mmol/L Desirable 
200-239 mg/dL 5.2-6.2 mmol/L  Borderline high 
240 mg/dL and above Above 6.2 mmol/L High 
   
LDL cholesterol 
U.S. and some other 
countries  
Canada and most of 
Europe  
  
Below 70 mg/dL Below 1.8 mmol/L Ideal for people at very 
high risk of heart disease 
Below 100 mg/dL Below 2.6 mmol/L Ideal for people at risk of 
heart disease 
100-129 mg/dL 2.6-3.3 mmol/L  Near ideal 
130-159 mg/dL 3.4-4.1 mmol/L Borderline high 
160-189 mg/dL 4.1-4.9 mmol/L  High 
190 mg/dL and above Above 4.9 mmol/L Very high 
   
HDL cholesterol 
U.S. and some other 
countries  
Canada and most of Europe    
Below 40 mg/dL (men) Below 1 mmol/L (men) Poor 
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Below 50 mg/dL (women) Below 1.3 mmol/L (women) 
50-59 mg/dL 1.3-1.5 mmol/L Better 
60 mg/dL and above Above 1.5 mmol/L Best 
   
 
 
Triglycerides 
U.S. and some other 
countries  
Canada and most of 
Europe  
  
Below 150 mg/dL Below 1.7 mmol/L Desirable 
150-199 mg/dL 1.7-2.2 mmol/L Borderline high 
200-499 mg/dL 2.3-5.6 mmol/L  High 
500 mg/dL and above Above 5.6 mmol/L Very high 
 
5. Normal values for cholesterol and triglyercides (138) 
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10 Figures 
 
Figure 2.1 Anatomy of the abdominal aorta, its location and the arterial branches arise from it 
 
Figure 2.2 A closer view of the abdominal aorta and its branches including the iliacs 
 
Figure 2.3 An illustration of the arterial wall and its three layers in a cross section view 
 
Figure 2.4 Aneurysm types, an illustration of true and false aneurysms 
 
Figure 2.5 Stages of aneurysmal degeneration  
 
Figure 2.6 Diagram of an open AAA Repair 
 
Figure 2.7 Example of the stent-grafts used in EVAR 
 
Figure 2.8 Diagram of an Endovascular Aneurysm Repair (EVAR) 
  
Figure 3.1 The inflammatory process involved in the formation of atherosclerosis 
 
Figure 4.1 A sound waveform 
 
Figure 4.2 A graph showing the impact of ultrasound frequency on attenuation  
 
Figure 4.3 Reflection of Ultrasound 
 
Figure 4.4 Snells Law 
 
Figure 4.5 Diagram of the operation of an ultrasound transducer 
 
Figure 4.6 Direction of ultrasound beams in a curvilinear transducer 
 
Figure 4.7 Block diagram of a B-mode scanner 
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Figure 4.8 Effect of the Doppler angle in the sonogram 
 
Figure 4.9 Pulse-wave and Colour Doppler image 
 
Figure 4.10 Transverse B-mode image of an AAA 
 
Figure 4.11 Longitudinal B-mode image of an AAA 
 
Figure 4.12 Components of a CT machine 
 
Figure 4.13 CT image of an AAA 
 
Figure 5.1 GE Logiq 9 Ultrasound Machine 
 
Figure 5.2 Curvilinear Transducer 
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11 Abbreviations 
 
AAA  Abdominal Aortic Aneurysm 
HTN   Hypertension 
DM     Diabetes Mellitus  
SMA   Superior Mesenteric Artery  
IMA    Inferior Mesenteric Artery  
MMP  Matrix Metalloproteinases  
NF κb Nuclear Factor KappaB  
ETS    E-twentysix  
CAD   Coronary Artery Disease  
ApoE  Apolipoprotein- E  
LDL    Low Density Lipoprotein 
HDL    High Density Lipoprotein 
CML    Carboxymethyllysine  
EVAR  Endovascular AAA Repair  
MASS  Multicentre Aneurysm Screening Study  
rAAA   Ruptured AAA  
LYG     Life Years Gained  
QALY  Quality Adjusted Life Years  
USPSTF United States Preventive Services Task Force  
TGC     Time gain compensation  
MHz      Mega Hertz 
PRF       Pulse Repetition Frequency  
CT         Computed Tomography 
BMI       Body Mass Index 
WHO     World Health Organisation 
GE         General Electric 
IHD       Ischemic Heart Disease  
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TIA       Transient Ischemic Attack 
CVA      Cardiovascular Attack 
GP         General Practitioner 
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Abstract 
Introduction 
AAA screening programmes have proven to be beneficial and cost effective worldwide for males 
greater than 65 years of age, with 4.9% males of 65–75 years of age having an un-diagnosed AAA at 
screening, resulting in a 42% reduction in the risk of rupture in an English population. This study 
assessed the incidence of AAA and risk factors for atherosclerosis in Irish males of 55–75 years. 
Methods 
From April 2006 to December 2007, males between the ages of 55 and 75 years, living within the 
catchment area of Blanchardstown Hospital were invited for AAA screening using duplex ultrasound 
and cardiovascular risk factor screening. 
Results 
1.9% (17/904) of the study population had previously un-diagnosed aneurysms  detected, with sizes 
ranging from 3.0 cm to 5.8 cm (0.6% in 55–65 years old (yo) and 4.2% in 65–75 yo, p < 0.01). 33% 
 113 
(302/904) of patients had hyperlipidaemia, while 16% of those with a previous diagnosis of 
hyperlipidaemia, were inadequately controlled on the test date. 31% of patients had a single elevated 
blood pressure reading, meriting further investigation for possible hypertension. 3% (28/904) of all 
patients had a raised glucose levels which had not previously been identified and of those who had a 
previous history of DM, 46% had abnormal glucose levels. 16% of patients (93/573) were morbidly 
obese (BMI > 30) and 64% (292/573) were overweight. 
Conclusion 
The incidence of AAAs in 65–75-year-old men is similar to international figures. This study confirms 
that screening for hyperlipidaemia, hypercholesterolaemia, obesity and hypertension may be 
worthwhile in all males over 55 years, while AAA screening should be reserved for 65–75-year-old 
Irish males. 
Keywords: Abdominal Aortic Aneurysm ; Screening; Cardiovascular risk factors; Obesity; 
Hyperlipidaemia; Hypercholesterolaemia 
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Introduction 
Cardiovascular disease accounted for 43% of all deaths in Ireland in 1997.1 The incidence of 
abdominal aortic aneurysms  (AAAs) has increased in the last two decades, due in part to an ageing 
population, with increasing number of smokers and also improved detection.2 Ruptured AAAs cause 
1.3% of all deaths among males between the ages of 65–85 years.2 One third of untreated AAAs will 
rupture, with an associated mortality rate of 65–85%, (half of these deaths occurring prior to arriving 
 114 
to surgery)3, 4 and 5. However, elective repair of these aneurysms  has a reported mean 30-day 
mortality of 2–6%.6 and 7  
AAA screening by ultrasound fulfils all WHO criteria for screening and is non-invasive using duplex 
ultrasound, with a sensitivity of 98.9% and a specificity of 99.9%.8, 9, 10, 11 and 12 AAA screening 
programmes have proven to be beneficial and cost-effective worldwide for males greater than 65 
years of age,13with 4.9% males of 65 years of age and over having an un-diagnosed AAA at 
screening, resulting in a 42% reduction in the risk of rupture14 in an English population. In 
Gloucestershire a population screening programme performed ultrasound scanning for all men at age 
65. If the aorta was less than 26 mm in diameter they were reassured and discharged, as aneurysm  
disease can be ruled out for 95% of these patients.15, 16, 17, 18, 19 and 20 
Risk factors for AAA formation include male sex, smoking, atherosclerosis as well as age21 therefore 
AAA screening provides an opportunity to identify patients with atherosclerotic risk factors. This 
would allow intervention to reduce both AAA expansion rates, and also to reduce other cardiovascular 
risk factors to improve future outcome. 
This study assessed the incidence of screening detected AAAs in a population of Irish males from 55 
to 75 years of age, with a view to identifying the ideal age group for screening. Furthermore patients 
were stratified for cardiovascular risk factors, to see if they might potentially benefit from 
medical/behavioural management. 
Materials and Methods 
A cardiovascular risk factor study was initiated by the vascular department in Connolly Hospital, 
Blanchardstown in Dublin from April 2006 to December 2008. Males between the ages of 55–75 
years, living within the catchment area of the hospital, who were identified from the registers of 
General Practitioners, were studied. Exclusion criteria included patients with terminal medical 
conditions or a previous history of AAA. 
These patients were invited to attend the vascular unit for AAA and cardiovascular risk factor 
screening. Patients fasted for a minimum of eight hours to enable a fasting lipid and triglyceride 
profile to be obtained and also to reduce bowel gas thereby improving ultrasound imaging of the 
aorta. Ethical approval was granted by the hospital's ethical committee and informed consent was 
obtained from every patient in the study. 
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The screening programme consisted of three parts:  
• Duplex ultrasound of aorta  
• Clinical risk factor assessment 
• Fasting lipid profile 
Duplex ultrasound of the aorta was performed in a standard way by a team of accredited vascular 
technologists with the patients in a supine position using a curvilinear 3.5 MHz transducer ultrasound 
probe (General Electric Logic 9). The protocol was taken from the Society for Vascular Technology 
of Great Britain and Ireland.22 If the aortic  diameter was less then 26 mm, the patients were 
discharged, as aneurysm  disease can be ruled out in 95% of these patients.23 Follow-up was defined 
as per international guidelines. 
A clinical nurse specialist met with each patient. Their blood pressure, height, weight and body mass 
index (BMI) were recorded. Normal blood pressure values were defined as less than 140 mmHg 
systolic and 90 mmHg diastolic. Finger prick tests were performed for total cholesterol, triglyceride 
and glucose estimation using the Cholestech LDX® System (Cholestech, California). Normal BMI 
was defined as between 18 and 25.24 Normal cholesterol values, including high density lipoprotein 
(HDL) and low density lipoprotein (LDL), as well as triglyceride values were defined per standard 
guidelines. 
A fasting serum total cholesterol of 5.0 mm/mol or greater was classed as hypercholesterolaemia. An 
abnormal glucose was defined as a fasting serum glucose of 7.0 mm/mol or greater.25 All abnormal 
finger prick tests were confirmed using standard blood samples. The nurse specialist discussed the 
patient's lifestyle and advised them on changes which would help them prevent or control their risk 
factors. 
The results of the risk profile and the recommendations for treatment were referred back to the family 
practitioner for follow-up. Patients with AAAs were followed up in the Vascular Diagnostic Unit of 
Connolly Hospital. 
Statistical comparison between the two groups was by Chi-squared test with p < 0.05 considered 
significant. 
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Results 
Using the general practitioners' register, 1414 patients were invited to attend and a total of 904 
patients accepted the invitation (64%). Of these, 568 (63%) were aged between 55 and 64 years 
(Group A) and 336 (37%) were aged between 65 and 75 years (Group B). The two groups were 
analysed together and then compared to assess their relative risks. 
Abdominal aortic aneurysm  
All patients underwent ultrasound of the aorta with 17 (1.9%) having previously un-diagnosed 
aneurysms  with sizes ranging from 3.0 cm to 5.8 cm. The incidence of AAA was found to be 0.6% 
in group A and 4.2% in group B (p < 0.01). 
Two aortas were not successfully imaged due to morbid obesity and these patients declined further 
attempts at imaging. 
Risk factors 
Smoking 
A total of 11% (104/904) of patients were smokers. There were 6% (58/904) ex-smokers and 82% had 
never smoked. Smoking cessation advice was offered to all smokers. 
Hypertension (Table 1) 
Six patients did not have their blood pressures (BP) recorded as the cuff diameter available was too 
small to measure the level accurately. 33% (294/904) of patients who had a previous history of 
hypertension and 68% of these had an isolated elevated blood pressure, despite having previously 
been prescribed an anti-hypertensive. 31% (278/898) of patients with no previous history had a single 
elevated blood pressure measurement, suggestive of hypertension. 
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Table 1.  
Single raised blood pressure reading in Group A (55–64 yo) and Group B (65–75 yo) 
 55–64 65–75 Total P 
Single elevated blood pressure 269 217 486 p < 0.00001 
Known hypertension poorly controlled 105 98 200  
No previous history 164 119 278  
Hypercholesterolaemia (Table 2) 
26% (234/904) of patients had a previous history of hypercholesterolaemia, with 16% of these being 
inadequately controlled. 33% (302/904) of patients were newly diagnosed with 
hypercholesterolaemia. 
Table 2.  
Cholesterol and lipoprotein levels in Group A (55–64 yo) and Group B (65–75 yo) 
 55–64 65–75 Total P 
Elevated cholesterol 234 105 339 p < 0.01 
Hx hypercholesterolaemia poorly controlled 19 18 37  
Un-diagnosed hypercholesterolaemia 215 87 302  
HDL < 1 221 82 303  
LDL > 3 279 95 374  
 
As high density lipoprotein (HDL) and low density lipoprotein (LDL) values are independent risk 
factors for AAA and atherosclerosis development for these values were also analysed.[6], 13, 26, 27 and 28 
From our results 33% (303/904) of the screened population had HDL level of less than 1 mmol/l and 
41% (374/904) had LDL level of greater than 3 mmol/l. 
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Diabetes mellitus (DM) (Table 3) 
6% (55/904) of patients had an elevated fasting blood glucose level; 49% (27/55) of these had a 
previous history of diabetes mellitus and had poor blood sugar control. 3% (28/904) of patients had 
previously undetected elevated glucose levels in excess of 7 mmol/l and were referred to their GP for 
further investigation and follow-up (Table 3). 
Table 3.  
Diabetes mellitus – poorly controlled and single elevated fasting blood glucose in Group A (55–64 
yo) and Group B (65–75 yo) 
 55–64 65–75 Total P 
Elevated blood glucose 26 29 55 p < 0.02 
Hx diabetes mellitus poorly controlled 8 19 27  
No history 18 10 28  
Body mass index (Table 4) 
Of the patients who agreed to have their body mass index measured, 16% (93/573) were morbidly 
obese (BMI > 30) and 64% (367/573) were overweight. Overweight patients received lifestyle advice 
from the nurse specialist and a risk profile was sent to their GP. 
Table 4.  
Body mass index in Group A (55–64 yo) and Group B (65–75 yo) including those who declined 
measurement 
BMI 55–64 65–75 Total 
BMI > 30 70 23 93 
30< = BMI > = 25 270 97 367 
<25 BMI 76 37 113 
Declined 152 179 331 
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Discussion 
Abdominal aortic aneurysm  screening has been shown to be cost effective in England in men 
greater than 65 years of age, significantly reducing the risk of rupture.29 However in the population of 
75 years and older an invitation to screening has not been shown to reduce all-cause mortality, since 
AAA-related mortality accounts for a small number of deaths in older men.30, 31 and 32 What is less 
clear, however is the cost-effectiveness of screening for AAA in men between 55 and 65 years of 
age.6, 13 and 33 
This study assessed the effectiveness of studying a population of Irish males for AAA. This study had 
an attendance rate of 64% comparable to other Irish studies,1 and slightly less than other published 
screening studies.[34], [35] and [36] In men between 65 and 75 years, 4.2% had AAAs detected, which is 
comparable to incidences found in this age group in England and the United States.[10], [11], [27] and [28] 
This would suggest that AAA screening in this age group in Ireland is justified. The incidence of 
screening detected AAAs in 55–64-year-old men in Ireland was 0.6%, which suggests that duplex 
screening is not justified or cost-effective in this group (p < 0.01). 
Ireland has a high incidence of cardiovascular disease as previously reported and supported by these 
results. The results of this study suggest that screening for cardiovascular risk factors is justified in 
Irish males over 55 years. The number of people that never smoked at 82% was quite surprising and 
suggests significant under reporting by the invitees, reflecting the negative social aspects of smoking 
currently in Ireland in the aftermath of the smoking ban. 
The incidence of hyperlipidaemia was notable in this study population. In patients between 55 and 65 
years old, 49% had an abnormally elevated lipid profile. These patients were educated with dietary 
advice, recommendations for possible statin therapy if indicated, and urgent referral back to their 
family doctor for further investigation and management. In patients aged 55–64 years old, 41% had a 
raised cholesterol level, compared with 31% of 65–74 years old (p < 0.01). As this is a significant 
difference, it is suggested that cholesterol and triglyceride screening is worthwhile in all males 
between 55 and 75 years of age. 
Blood sugar levels were elevated in 6% (55/904) of patients 46% of them with known DM suggesting 
poor control and 3% of patients with no history of DM. All patients were referred for further 
investigation and management to their family practitioners. 
80% of the study population was found to be overweight with 16% morbidly obese. These results are 
higher than those previously published in this country and indicate that obesity is becoming a 
significant health problem.1 
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54% of all males had a single elevated blood pressure, which is suggestive of hypertension. 68% of 
those with previously documented hypertension had a raised blood pressure measurement, which 
could indicate poor control. Those with elevated blood pressure readings were referred to their family 
practitioner for further blood pressure measurements in order to determine the presence of 
hypertension. 
The results of this study would indicate that undiagnosed and under-treated hypertension, diabetes 
mellitus and hypercholesterolaemia are common in Irish males over 50 years of age. Control of 
hypercholesterolaemia has been shown to have a 24–35% reduction in coronary events as well as 30% 
reduction in cerebrovascular events.37 and 38 Lifestyle modifications would have a significant impact on 
reducing these patients' risk of a cardiovascular event.39 and 40 This study shows the benefits of AAA 
screening in Irish males of 65–75 years; however, screening in males less than 65 years cannot be 
justified. In the younger group, screening for cardiovascular risk factors is beneficial both to 
determine the rate of un-diagnosed cardiovascular disease and to monitor and control these risk 
factors. 
A number of conclusions can be drawn from this study, which is the first report of AAA screening in 
Irish males. The incidence of AAAs in 65–75-year-old men is similar to that in Britain and USA. This 
suggests that the recent recommendation of the introduction of a national screening programme in 
Britain should be imitated in Ireland.41 The lower incidence of AAAs in Irish males under 65 does not 
justify screening in this age group. 
The high incidence of cardiovascular risk factors in all males over 55 years is hardly surprising given 
the recognised prevalence of atherosclerotic disease in Ireland. This study confirms that screening for 
hyperlipidaemia, hypercholesterolaemia, obesity and hypertension in this age group may be 
worthwhile. 
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